Adipocyte - breast, donor1.CNhs11051.11376-118A8 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adipocyte - breast, donor2.CNhs11969.11327-117E4 | 676.56 | 49.89 | 3.64 | 1.50 | 0.21 |
Adipocyte - omental, donor1.CNhs11054.11473-119C6 | 385.79 | 52.72 | 1.27 | 0.42 | 0.14 |
Adipocyte - omental, donor2.CNhs12067.11474-119C7 | 415.30 | 61.04 | 1.00 | 3.00 | 1.00 |
Adipocyte - omental, donor3.CNhs12068.11475-119C8 | 540.82 | 49.61 | 4.47 | 1.34 | 0.45 |
Adipocyte - perirenal, donor1.CNhs12069.11476-119C9 | 327.13 | 43.62 | 10.47 | 1.74 | 0.87 |
Adipocyte - subcutaneous, donor1.CNhs12494.11259-116F8 | 992.94 | 83.59 | 2.53 | 2.53 | 5.07 |
Adipocyte - subcutaneous, donor2.CNhs11371.11336-117F4 | 600.13 | 60.01 | 1.26 | 1.26 | 0.00 |
Adipocyte - subcutaneous, donor3.CNhs12017.11408-118E4 | 1525.06 | 53.80 | 4.96 | 3.92 | 0.26 |
Alveolar Epithelial Cells, donor1.CNhs11325.11510-119G7 | 579.44 | 76.91 | 1.23 | 0.74 | 2.21 |
Alveolar Epithelial Cells, donor2.CNhs12084.11590-120G6 | 1191.84 | 170.96 | 4.88 | 4.88 | 1.40 |
Amniotic Epithelial Cells, donor1.CNhs11341.11533-120A3 | 591.32 | 65.75 | 1.09 | 0.44 | 0.44 |
Amniotic Epithelial Cells, donor3.CNhs12125.11694-123A2 | 627.77 | 69.11 | 1.06 | 1.06 | 0.26 |
Anulus Pulposus Cell, donor1.CNhs10876.11248-116E6 | 458.68 | 82.55 | 3.47 | 2.23 | 1.36 |
Anulus Pulposus Cell, donor2.CNhs12064.11463-119B5 | 834.46 | 72.58 | 3.98 | 3.31 | 1.33 |
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1).CNhs13339.12642-134G5 | 385.24 | 67.90 | 9.41 | 2.69 | 2.02 |
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2).CNhs13358.12740-135I4 | 368.85 | 62.68 | 10.25 | 2.41 | 1.81 |
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31).CNhs13349.12652-134H6 | 372.46 | 90.56 | 7.30 | 2.19 | 0.73 |
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32).CNhs13369.12750-136A5 | 341.55 | 71.24 | 5.86 | 3.42 | 0.00 |
Astrocyte - cerebellum, donor1.CNhs11321.11500-119F6 | 964.90 | 79.78 | 1.35 | 0.62 | 0.62 |
Astrocyte - cerebellum, donor2.CNhs12081.11580-120F5 | 1298.46 | 94.25 | 4.69 | 3.06 | 1.22 |
Astrocyte - cerebellum, donor3.CNhs12117.11661-122F5 | 1085.18 | 90.27 | 1.88 | 1.57 | 0.63 |
Astrocyte - cerebral cortex, donor1.CNhs10864.11235-116D2 | 411.32 | 44.08 | 3.72 | 0.86 | 0.00 |
Astrocyte - cerebral cortex, donor2.CNhs11960.11316-117D2 | 759.52 | 50.23 | 3.28 | 1.64 | 0.68 |
Astrocyte - cerebral cortex, donor3.CNhs12005.11392-118C6 | 554.40 | 50.97 | 2.01 | 2.13 | 0.63 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1.CNhs12331.10821-111C2 | 1086.60 | 103.92 | 2.29 | 1.45 | 0.38 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2.CNhs12332.10822-111C3 | 1161.39 | 98.85 | 1.15 | 0.66 | 0.41 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3.CNhs12333.10823-111C4 | 1138.24 | 103.03 | 1.42 | 0.87 | 0.55 |
Basophils, donor1.CNhs12546.12241-129G9 | 1136.04 | 223.43 | 1.97 | 0.39 | 3.93 |
Basophils, donor2.CNhs12563.12242-129H1 | 548.49 | 115.15 | 0.77 | 1.15 | 1.15 |
Basophils, donor3.CNhs12575.12243-129H2 | 1048.41 | 119.21 | 1.08 | 0.31 | 1.70 |
Bronchial Epithelial Cell, donor4.CNhs12054.11453-119A4 | 464.31 | 48.73 | 1.84 | 0.92 | 0.92 |
Bronchial Epithelial Cell, donor5.CNhs12058.11457-119A8 | 743.38 | 50.60 | 1.81 | 1.20 | 0.60 |
Bronchial Epithelial Cell, donor6.CNhs12062.11461-119B3 | 644.11 | 92.44 | 7.03 | 2.22 | 1.11 |
Burkitt's lymphoma cell line:DAUDI.CNhs10739.10422-106C8 | 850.51 | 58.33 | 1.39 | 0.39 | 0.62 |
Burkitt's lymphoma cell line:RAJI.CNhs11268.10476-106I8 | 378.17 | 56.30 | 0.28 | 0.85 | 0.14 |
CD133+ stem cells - adult bone marrow derived, pool1.CNhs12552.12224-129F1 | 562.83 | 79.57 | 1.17 | 1.76 | 1.47 |
CD14+ Monocytes, donor1.CNhs10852.11224-116B9 | 814.93 | 101.94 | 1.11 | 1.66 | 5.54 |
CD14+ Monocytes, donor2.CNhs11954.11305-117B9 | 1857.24 | 116.52 | 4.21 | 2.41 | 1.20 |
CD14+ Monocytes, donor3.CNhs11997.11381-118B4 | 1065.52 | 98.31 | 1.74 | 2.17 | 1.30 |
CD14+ monocyte derived endothelial progenitor cells, donor1.CNhs10858.11229-116C5 | 335.65 | 93.82 | 0.90 | 2.02 | 0.45 |
CD14+ monocyte derived endothelial progenitor cells, donor2.CNhs11897.11310-117C5 | 618.64 | 77.41 | 0.97 | 1.30 | 0.00 |
CD14+ monocyte derived endothelial progenitor cells, donor3.CNhs11904.11386-118B9 | 860.30 | 106.38 | 0.26 | 0.00 | 1.29 |
CD14+ monocytes - mock treated, donor1.CNhs13468.11863-125A9 | 724.81 | 133.04 | 3.78 | 1.45 | 2.62 |
CD14+ monocytes - mock treated, donor2.CNhs13484.11873-125C1 | 1086.02 | 123.94 | 0.76 | 3.02 | 4.53 |
CD14+ monocytes - mock treated, donor3.CNhs13491.11883-125D2 | 1000.42 | 149.19 | 0.97 | 1.21 | 4.37 |
CD14+ monocytes - treated with B-glucan, donor1.CNhs13474.11869-125B6 | 506.93 | 152.94 | 1.39 | 1.39 | 2.32 |
CD14+ monocytes - treated with B-glucan, donor2.CNhs13489.11879-125C7 | 960.08 | 108.14 | 1.64 | 4.52 | 1.23 |
CD14+ monocytes - treated with B-glucan, donor3.CNhs13495.11889-125D8 | 848.91 | 125.12 | 2.48 | 0.93 | 2.17 |
CD14+ monocytes - treated with BCG, donor1.CNhs13465.11860-125A6 | 574.52 | 162.26 | 4.03 | 0.86 | 1.15 |
CD14+ monocytes - treated with BCG, donor2.CNhs13475.11870-125B7 | 834.32 | 116.04 | 3.33 | 2.31 | 0.51 |
CD14+ monocytes - treated with BCG, donor3.CNhs13543.11880-125C8 | 546.51 | 116.35 | 2.36 | 1.18 | 0.95 |
CD14+ monocytes - treated with Candida, donor1.CNhs13473.11868-125B5 | 528.50 | 133.42 | 6.21 | 1.38 | 1.03 |
CD14+ monocytes - treated with Candida, donor2.CNhs13488.11878-125C6 | 850.10 | 99.40 | 0.65 | 3.87 | 0.65 |
CD14+ monocytes - treated with Candida, donor3.CNhs13494.11888-125D7 | 636.50 | 111.05 | 0.00 | 2.71 | 1.35 |
CD14+ monocytes - treated with Cryptococcus, donor1.CNhs13472.11867-125B4 | 550.80 | 130.45 | 3.95 | 3.01 | 2.82 |
CD14+ monocytes - treated with Cryptococcus, donor2.CNhs13487.11877-125C5 | 898.13 | 135.91 | 2.46 | 3.27 | 1.36 |
CD14+ monocytes - treated with Cryptococcus, donor3.CNhs13546.11887-125D6 | 416.41 | 122.25 | 1.12 | 3.15 | 1.80 |
CD14+ monocytes - treated with Group A streptococci, donor1.CNhs13469.11864-125B1 | 760.62 | 158.55 | 4.29 | 2.14 | 1.84 |
CD14+ monocytes - treated with Group A streptococci, donor2.CNhs13532.11874-125C2 | 941.61 | 126.13 | 1.60 | 2.57 | 0.32 |
CD14+ monocytes - treated with Group A streptococci, donor3.CNhs13492.11884-125D3 | 930.24 | 158.56 | 2.56 | 2.56 | 2.56 |
CD14+ monocytes - treated with IFN + N-hexane, donor1.CNhs13466.11861-125A7 | 453.88 | 137.22 | 3.63 | 1.65 | 0.33 |
CD14+ monocytes - treated with IFN + N-hexane, donor2.CNhs13476.11871-125B8 | 823.19 | 109.51 | 3.59 | 2.39 | 1.00 |
CD14+ monocytes - treated with IFN + N-hexane, donor3.CNhs13490.11881-125C9 | 584.35 | 110.82 | 2.98 | 0.85 | 2.56 |
CD14+ monocytes - treated with Salmonella, donor1.CNhs13471.11866-125B3 | 627.43 | 138.72 | 3.48 | 2.90 | 1.74 |
CD14+ monocytes - treated with Salmonella, donor2.CNhs13485.11876-125C4 | 1328.25 | 133.34 | 0.57 | 0.57 | 1.13 |
CD14+ monocytes - treated with Salmonella, donor3.CNhs13493.11886-125D5 | 1052.57 | 153.21 | 1.25 | 3.74 | 1.25 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1.CNhs13467.11862-125A8 | 893.19 | 140.95 | 3.01 | 2.01 | 2.26 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2.CNhs13483.11872-125B9 | 1263.55 | 125.16 | 2.61 | 1.56 | 2.09 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3.CNhs13544.11882-125D1 | 614.64 | 116.41 | 1.95 | 2.17 | 1.09 |
CD14+ monocytes - treated with lipopolysaccharide, donor1.CNhs13470.11865-125B2 | 539.41 | 116.24 | 3.03 | 2.42 | 1.21 |
CD14+ monocytes - treated with lipopolysaccharide, donor2.CNhs13533.11875-125C3 | 889.02 | 109.01 | 1.47 | 0.74 | 1.47 |
CD14+ monocytes - treated with lipopolysaccharide, donor3.CNhs13545.11885-125D4 | 412.35 | 107.91 | 2.22 | 1.27 | 1.90 |
CD14+CD16+ Monocytes, donor1.CNhs13541.11789-124B7 | 312.87 | 167.74 | 2.54 | 1.48 | 2.54 |
CD14+CD16+ Monocytes, donor2.CNhs13208.11801-124D1 | 291.69 | 150.74 | 3.19 | 1.06 | 3.61 |
CD14+CD16+ Monocytes, donor3.CNhs13549.11912-125G4 | 320.15 | 169.82 | 1.05 | 1.26 | 2.52 |
CD14+CD16- Monocytes, donor1.CNhs13224.11788-124B6 | 312.72 | 123.45 | 2.47 | 1.35 | 8.42 |
CD14+CD16- Monocytes, donor2.CNhs13216.11799-124C8 | 451.13 | 144.17 | 1.65 | 0.75 | 6.46 |
CD14+CD16- Monocytes, donor3.CNhs13540.11910-125G2 | 753.32 | 179.37 | 0.80 | 0.48 | 8.52 |
CD14-CD16+ Monocytes, donor1.CNhs13229.11790-124B8 | 143.65 | 165.88 | 0.29 | 0.86 | 4.28 |
CD14-CD16+ Monocytes, donor2.CNhs13207.11800-124C9 | 266.75 | 163.71 | 3.18 | 1.79 | 1.99 |
CD14-CD16+ Monocytes, donor3.CNhs13548.11911-125G3 | 287.70 | 175.36 | 0.00 | 0.55 | 2.19 |
CD19+ B Cells (pluriselect), donor090309, donation1.CNhs12177.12189-129B2 | 329.11 | 114.40 | 0.00 | 0.00 | 0.00 |
CD19+ B Cells (pluriselect), donor090309, donation2.CNhs12179.12194-129B7 | 389.40 | 123.97 | 1.64 | 1.09 | 2.18 |
CD19+ B Cells (pluriselect), donor090309, donation3.CNhs12181.12199-129C3 | 357.58 | 105.85 | 0.89 | 0.89 | 0.00 |
CD19+ B Cells (pluriselect), donor090325, donation1.CNhs12531.12151-128F9 | 324.74 | 104.98 | 1.28 | 0.85 | 2.13 |
CD19+ B Cells (pluriselect), donor090325, donation2.CNhs12175.12174-128I5 | 573.77 | 138.54 | 1.60 | 0.40 | 0.80 |
CD19+ B Cells (pluriselect), donor090612, donation1.CNhs12183.12204-129C8 | 414.40 | 135.07 | 3.45 | 1.15 | 0.00 |
CD19+ B Cells (pluriselect), donor090612, donation2.CNhs12185.12209-129D4 | 432.98 | 122.95 | 1.32 | 0.00 | 0.00 |
CD19+ B Cells (pluriselect), donor090612, donation3.CNhs12188.12214-129D9 | 429.32 | 118.30 | 2.86 | 0.95 | 0.95 |
CD19+ B Cells, donor1.CNhs12343.11544-120B5 | 740.55 | 104.17 | 2.85 | 0.57 | 0.00 |
CD19+ B Cells, donor2.CNhs12352.11624-122B4 | 680.61 | 93.37 | 4.11 | 1.76 | 0.00 |
CD19+ B Cells, donor3.CNhs12354.11705-123B4 | 804.30 | 105.89 | 1.91 | 0.76 | 0.00 |
CD34+ Progenitors, donor1.CNhs13227.11545-120B6 | 282.85 | 99.13 | 1.32 | 5.29 | 0.00 |
CD34+ Progenitors, donor2.CNhs12205.11625-122B5 | 581.81 | 72.31 | 0.56 | 0.56 | 0.00 |
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1.CNhs12588.12225-129F2 | 507.28 | 76.38 | 2.11 | 0.53 | 0.26 |
CD4+ T Cells, donor1.CNhs10853.11225-116C1 | 753.99 | 81.83 | 0.98 | 0.79 | 0.00 |
CD4+ T Cells, donor2.CNhs11955.11306-117C1 | 869.73 | 88.82 | 8.25 | 2.75 | 0.00 |
CD4+ T Cells, donor3.CNhs11998.11382-118B5 | 693.49 | 90.26 | 1.64 | 1.23 | 0.00 |
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1.CNhs13203.11793-124C2 | 335.21 | 111.85 | 1.67 | 1.67 | 0.33 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor1.CNhs13238.11780-124A7 | 177.95 | 102.01 | 1.63 | 0.98 | 0.33 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor2.CNhs13235.11796-124C5 | 307.27 | 117.42 | 2.37 | 1.42 | 0.00 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor3.CNhs13513.11907-125F8 | 311.72 | 97.41 | 3.90 | 0.00 | 0.00 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1.CNhs13204.11794-124C3 | 328.22 | 110.85 | 2.34 | 1.67 | 0.33 |
CD4+CD25+CD45RA- memory regulatory T cells, donor1.CNhs13195.11782-124A9 | 305.80 | 104.00 | 2.06 | 1.18 | 0.00 |
CD4+CD25+CD45RA- memory regulatory T cells, donor2.CNhs13206.11797-124C6 | 329.86 | 124.50 | 1.77 | 1.77 | 0.44 |
CD4+CD25+CD45RA- memory regulatory T cells, donor3.CNhs13538.11908-125F9 | 263.76 | 132.42 | 1.90 | 1.62 | 0.00 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2.CNhs13811.11916-125G8 | 221.85 | 136.80 | 2.82 | 1.67 | 0.38 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3.CNhs13812.11920-125H3 | 181.17 | 126.16 | 2.99 | 0.78 | 0.13 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2.CNhs13813.11913-125G5 | 197.00 | 89.95 | 3.45 | 1.15 | 0.16 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3.CNhs13814.11917-125G9 | 172.44 | 83.18 | 2.21 | 1.38 | 0.00 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1.CNhs13202.11791-124B9 | 210.69 | 99.11 | 1.74 | 1.74 | 0.29 |
CD4+CD25-CD45RA+ naive conventional T cells, donor1.CNhs13223.11784-124B2 | 281.60 | 72.36 | 2.97 | 1.63 | 0.30 |
CD4+CD25-CD45RA+ naive conventional T cells, donor2.CNhs13205.11795-124C4 | 427.26 | 74.91 | 1.61 | 2.68 | 0.00 |
CD4+CD25-CD45RA+ naive conventional T cells, donor3.CNhs13512.11906-125F7 | 406.64 | 98.26 | 3.14 | 4.18 | 1.05 |
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1.CNhs13215.11792-124C1 | 294.26 | 98.35 | 2.49 | 1.59 | 0.34 |
CD4+CD25-CD45RA- memory conventional T cells, donor1.CNhs13239.11786-124B4 | 231.47 | 113.43 | 0.77 | 1.92 | 0.00 |
CD4+CD25-CD45RA- memory conventional T cells, donor2.CNhs13237.11798-124C7 | 278.68 | 100.00 | 2.06 | 1.72 | 0.34 |
CD4+CD25-CD45RA- memory conventional T cells, donor3.CNhs13539.11909-125G1 | 469.60 | 112.34 | 2.53 | 1.01 | 0.25 |
CD8+ T Cells (pluriselect), donor090309, donation1.CNhs12176.12186-129A8 | 455.23 | 99.39 | 0.64 | 1.27 | 0.64 |
CD8+ T Cells (pluriselect), donor090309, donation2.CNhs12178.12191-129B4 | 347.68 | 106.78 | 1.30 | 0.65 | 0.00 |
CD8+ T Cells (pluriselect), donor090309, donation3.CNhs12180.12196-129B9 | 335.51 | 112.15 | 0.00 | 0.95 | 0.00 |
CD8+ T Cells (pluriselect), donor090325, donation1.CNhs12201.12148-128F6 | 503.82 | 94.86 | 0.90 | 1.36 | 0.45 |
CD8+ T Cells (pluriselect), donor090325, donation2.CNhs12199.12171-128I2 | 479.44 | 105.59 | 0.77 | 1.41 | 0.38 |
CD8+ T Cells (pluriselect), donor090612, donation1.CNhs12182.12201-129C5 | 299.83 | 102.44 | 2.50 | 0.00 | 1.25 |
CD8+ T Cells (pluriselect), donor090612, donation2.CNhs12184.12206-129D1 | 459.35 | 109.39 | 2.37 | 0.95 | 0.95 |
CD8+ T Cells (pluriselect), donor090612, donation3.CNhs12187.12211-129D6 | 472.97 | 101.00 | 1.64 | 0.82 | 0.82 |
CD8+ T Cells, donor1.CNhs10854.11226-116C2 | 498.37 | 86.49 | 1.81 | 0.81 | 0.20 |
CD8+ T Cells, donor2.CNhs11956.11307-117C2 | 735.46 | 73.81 | 4.81 | 2.67 | 0.00 |
CD8+ T Cells, donor3.CNhs11999.11383-118B6 | 754.82 | 83.42 | 2.03 | 1.59 | 0.14 |
Cardiac Myocyte, donor1.CNhs12341.11525-119I4 | 2703.82 | 87.77 | 0.00 | 0.00 | 0.00 |
Cardiac Myocyte, donor2.CNhs12350.11605-120I3 | 833.01 | 48.96 | 6.04 | 0.00 | 1.34 |
Cardiac Myocyte, donor3.CNhs12571.11686-122I3 | 663.86 | 58.43 | 0.90 | 1.66 | 0.90 |
Chondrocyte - de diff, donor1.CNhs11923.11261-116G1 | 876.49 | 40.12 | 2.53 | 0.72 | 0.00 |
Chondrocyte - de diff, donor2.CNhs11372.11338-117F6 | 713.91 | 64.17 | 1.50 | 1.50 | 0.50 |
Chondrocyte - de diff, donor3.CNhs12020.11410-118E6 | 838.66 | 58.37 | 6.08 | 2.32 | 0.87 |
Chondrocyte - re diff, donor2.CNhs11373.11339-117F7 | 316.52 | 46.92 | 0.00 | 2.39 | 1.59 |
Chondrocyte - re diff, donor3.CNhs12021.11411-118E7 | 728.01 | 41.36 | 1.95 | 2.43 | 1.95 |
Ciliary Epithelial Cells, donor1.CNhs10871.11242-116D9 | 525.61 | 55.59 | 1.99 | 1.42 | 0.47 |
Ciliary Epithelial Cells, donor2.CNhs11966.11323-117D9 | 705.54 | 53.44 | 5.76 | 2.44 | 0.44 |
Ciliary Epithelial Cells, donor3.CNhs12009.11399-118D4 | 831.71 | 51.03 | 3.16 | 1.84 | 0.26 |
Clontech Human Universal Reference Total RNA, pool1.CNhs10608.10000-101A1 | 495.04 | 58.15 | 1.24 | 1.44 | 0.65 |
Corneal Epithelial Cells, donor1.CNhs11336.11526-119I5 | 654.64 | 103.10 | 1.82 | 0.73 | 0.73 |
Corneal Epithelial Cells, donor3.CNhs12123.11687-122I4 | 761.59 | 90.47 | 1.85 | 2.60 | 1.11 |
Dendritic Cells - monocyte immature derived, donor1, tech_rep1.CNhs10855.11227-116C3 | 324.22 | 76.27 | 0.32 | 0.65 | 0.32 |
Dendritic Cells - monocyte immature derived, donor1, tech_rep2.CNhs11062.11227-116C3 | 372.81 | 75.75 | 0.70 | 0.17 | 0.52 |
Dendritic Cells - monocyte immature derived, donor3.CNhs12000.11384-118B7 | 450.46 | 88.95 | 1.73 | 1.33 | 0.27 |
Dendritic Cells - plasmacytoid, donor1.CNhs10857.11228-116C4 | 377.05 | 77.27 | 1.43 | 1.19 | 0.24 |
Dendritic Cells - plasmacytoid, donor2.CNhs12196.11309-117C4 | 399.82 | 88.09 | 0.00 | 0.57 | 0.57 |
Dendritic Cells - plasmacytoid, donor3.CNhs12200.11385-118B8 | 358.83 | 70.21 | 0.74 | 1.11 | 0.37 |
Endothelial Cells - Aortic, donor0.CNhs10837.11207-116A1 | 856.86 | 78.31 | 1.19 | 1.39 | 0.20 |
Endothelial Cells - Aortic, donor1.CNhs12495.11263-116G3 | 1302.40 | 77.42 | 0.86 | 2.58 | 0.00 |
Endothelial Cells - Aortic, donor2.CNhs11375.11340-117F8 | 746.00 | 75.68 | 1.74 | 0.35 | 1.74 |
Endothelial Cells - Aortic, donor3.CNhs12022.11412-118E8 | 1093.87 | 59.92 | 2.26 | 0.57 | 0.00 |
Endothelial Cells - Artery, donor1.CNhs12496.11264-116G4 | 1307.16 | 80.12 | 4.19 | 4.61 | 0.42 |
Endothelial Cells - Artery, donor2.CNhs11977.11341-117F9 | 1035.27 | 79.51 | 6.05 | 2.20 | 0.55 |
Endothelial Cells - Artery, donor3.CNhs12023.11413-118E9 | 1212.17 | 76.49 | 1.67 | 3.34 | 0.84 |
Endothelial Cells - Lymphatic, donor1.CNhs10865.11236-116D3 | 413.73 | 42.38 | 2.58 | 2.84 | 0.26 |
Endothelial Cells - Lymphatic, donor2.CNhs11901.11317-117D3 | 603.02 | 47.67 | 0.36 | 0.36 | 0.71 |
Endothelial Cells - Lymphatic, donor3.CNhs11906.11393-118C7 | 792.28 | 36.15 | 1.00 | 0.67 | 0.67 |
Endothelial Cells - Microvascular, donor1.CNhs11925.11265-116G5 | 605.05 | 60.02 | 4.03 | 4.03 | 0.40 |
Endothelial Cells - Microvascular, donor2.CNhs11376.11342-117G1 | 472.89 | 51.70 | 2.28 | 0.76 | 0.00 |
Endothelial Cells - Microvascular, donor3.CNhs12024.11414-118F1 | 960.38 | 81.76 | 3.90 | 3.66 | 0.98 |
Endothelial Cells - Thoracic, donor1.CNhs11926.11266-116G6 | 577.97 | 53.31 | 2.21 | 0.74 | 0.74 |
Endothelial Cells - Thoracic, donor2.CNhs11978.11343-117G2 | 1028.88 | 82.63 | 7.29 | 1.62 | 0.00 |
Endothelial Cells - Umbilical vein, donor1.CNhs10872.11243-116E1 | 464.45 | 56.17 | 2.23 | 1.43 | 1.16 |
Endothelial Cells - Umbilical vein, donor2.CNhs11967.11324-117E1 | 1264.10 | 68.48 | 1.35 | 0.45 | 0.90 |
Endothelial Cells - Umbilical vein, donor3.CNhs12010.11400-118D5 | 1054.72 | 72.07 | 0.79 | 0.23 | 0.68 |
Endothelial Cells - Vein, donor1.CNhs12497.11267-116G7 | 1252.60 | 56.73 | 1.53 | 1.53 | 0.00 |
Endothelial Cells - Vein, donor2.CNhs11377.11344-117G3 | 754.67 | 63.60 | 0.00 | 1.90 | 0.95 |
Endothelial Cells - Vein, donor3.CNhs12026.11416-118F3 | 872.77 | 59.17 | 2.20 | 1.65 | 0.55 |
Eosinophils, donor2.CNhs12548.12245-129H4 | 1180.75 | 446.74 | 2.64 | 0.00 | 31.63 |
Eosinophils, donor3.CNhs12549.12246-129H5 | 1128.44 | 589.43 | 3.88 | 0.00 | 42.66 |
Esophageal Epithelial Cells, donor1.CNhs11323.11507-119G4 | 696.44 | 89.84 | 1.74 | 0.87 | 0.87 |
Ewing's sarcoma cell line:Hs 863.T.CNhs11836.10705-109H3 | 603.32 | 58.64 | 0.99 | 2.48 | 0.50 |
Fibroblast - Aortic Adventitial, donor1.CNhs10874.11245-116E3 | 323.67 | 53.82 | 3.55 | 1.14 | 1.01 |
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction).CNhs12581.14332-155F3 | 319.50 | 23.44 | 0.79 | 0.66 | 0.13 |
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction).CNhs12400.14311-155C9 | 554.17 | 22.66 | 2.29 | 1.72 | 0.57 |
Fibroblast - Aortic Adventitial, donor3.CNhs12011.11401-118D6 | 798.36 | 80.86 | 3.55 | 3.19 | 1.06 |
Fibroblast - Cardiac, donor1.CNhs12498.11268-116G8 | 911.66 | 58.31 | 4.49 | 2.24 | 2.80 |
Fibroblast - Cardiac, donor2.CNhs11378.11345-117G4 | 525.21 | 70.45 | 1.07 | 1.07 | 1.07 |
Fibroblast - Cardiac, donor3.CNhs12027.11417-118F4 | 709.91 | 67.09 | 4.19 | 1.23 | 0.74 |
Fibroblast - Cardiac, donor4.CNhs11909.11452-119A3 | 838.40 | 51.97 | 0.93 | 0.00 | 0.31 |
Fibroblast - Cardiac, donor5.CNhs12057.11456-119A7 | 517.02 | 44.05 | 2.29 | 1.62 | 0.13 |
Fibroblast - Cardiac, donor6.CNhs12061.11460-119B2 | 455.24 | 56.88 | 3.11 | 1.80 | 0.98 |
Fibroblast - Choroid Plexus, donor1.CNhs11319.11492-119E7 | 1236.14 | 55.85 | 1.97 | 0.45 | 0.61 |
Fibroblast - Choroid Plexus, donor2.CNhs12344.11572-120E6 | 700.63 | 62.23 | 1.15 | 1.15 | 0.00 |
Fibroblast - Conjunctival, donor1.CNhs11339.11531-120A1 | 1622.21 | 137.08 | 1.17 | 0.70 | 0.70 |
Fibroblast - Dermal, donor1.CNhs12499.11269-116G9 | 874.67 | 87.09 | 2.50 | 0.62 | 0.31 |
Fibroblast - Dermal, donor2.CNhs11379.11346-117G5 | 846.58 | 100.97 | 0.57 | 0.57 | 1.71 |
Fibroblast - Dermal, donor3.CNhs12028.11418-118F5 | 714.36 | 76.82 | 4.18 | 2.24 | 0.60 |
Fibroblast - Dermal, donor4.CNhs12052.11450-119A1 | 650.47 | 64.94 | 4.46 | 2.11 | 0.47 |
Fibroblast - Dermal, donor5.CNhs12055.11454-119A5 | 581.77 | 56.66 | 5.18 | 1.78 | 0.81 |
Fibroblast - Dermal, donor6.CNhs12059.11458-119A9 | 544.11 | 59.55 | 3.37 | 1.69 | 0.56 |
Fibroblast - Gingival, donor1.CNhs10866.11237-116D4 | 413.21 | 73.09 | 0.61 | 1.43 | 1.22 |
Fibroblast - Gingival, donor2.CNhs11961.11318-117D4 | 583.09 | 69.16 | 4.91 | 1.11 | 0.61 |
Fibroblast - Gingival, donor3.CNhs12006.11394-118C8 | 1281.45 | 78.84 | 1.45 | 1.65 | 0.21 |
Fibroblast - Gingival, donor4 (GFH2).CNhs10848.11222-116B7 | 460.95 | 73.66 | 2.38 | 1.19 | 0.00 |
Fibroblast - Gingival, donor5 (GFH3).CNhs11952.11303-117B7 | 1022.20 | 87.53 | 4.45 | 1.24 | 0.49 |
Fibroblast - Lymphatic, donor1.CNhs11322.11506-119G3 | 1832.15 | 99.21 | 1.82 | 0.91 | 0.91 |
Fibroblast - Lymphatic, donor3.CNhs12118.11667-122G2 | 1348.85 | 186.84 | 1.44 | 1.44 | 0.72 |
Fibroblast - Periodontal Ligament, donor1.CNhs10867.11238-116D5 | 347.45 | 66.16 | 1.68 | 0.51 | 1.52 |
Fibroblast - Periodontal Ligament, donor2.CNhs11962.11319-117D5 | 1031.23 | 80.70 | 2.38 | 1.00 | 1.50 |
Fibroblast - Periodontal Ligament, donor3.CNhs11907.11395-118C9 | 810.41 | 67.33 | 0.28 | 0.28 | 0.83 |
Fibroblast - Periodontal Ligament, donor4 (PL29).CNhs12493.11223-116B8 | 1207.63 | 92.62 | 0.88 | 2.19 | 0.44 |
Fibroblast - Periodontal Ligament, donor5 (PL30).CNhs11953.11304-117B8 | 722.39 | 78.46 | 5.21 | 2.76 | 0.31 |
Fibroblast - Periodontal Ligament, donor6 (PLH3).CNhs11996.11380-118B3 | 967.98 | 74.67 | 1.80 | 1.35 | 0.75 |
Fibroblast - Pulmonary Artery, donor1.CNhs10878.11250-116E8 | 330.20 | 52.41 | 2.04 | 1.13 | 1.47 |
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction).CNhs12405.14329-155E9 | 592.70 | 22.24 | 0.54 | 0.00 | 0.72 |
Fibroblast - skin dystrophia myotonica, donor1.CNhs11353.11556-120C8 | 580.24 | 50.40 | 1.49 | 0.43 | 0.43 |
Fibroblast - skin dystrophia myotonica, donor2.CNhs11354.11557-120C9 | 472.40 | 43.87 | 1.06 | 0.42 | 0.21 |
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction).CNhs12399.14308-155C6 | 463.34 | 33.01 | 1.20 | 0.30 | 0.60 |
Fibroblast - skin dystrophia myotonica, donor3.CNhs11913.11560-120D3 | 669.84 | 59.98 | 2.27 | 1.13 | 0.52 |
Fibroblast - skin normal, donor1 (nuclear fraction).CNhs12403.14323-155E3 | 544.14 | 30.14 | 1.55 | 0.52 | 0.26 |
Fibroblast - skin normal, donor1.CNhs11351.11553-120C5 | 542.90 | 56.58 | 2.23 | 1.12 | 0.37 |
Fibroblast - skin normal, donor2 (nuclear fraction).CNhs12582.14302-155B9 | 464.30 | 30.89 | 0.68 | 0.51 | 0.17 |
Fibroblast - skin normal, donor2.CNhs11914.11561-120D4 | 629.83 | 62.16 | 0.97 | 1.07 | 0.97 |
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction).CNhs12404.14326-155E6 | 614.42 | 29.79 | 1.51 | 0.50 | 0.50 |
Fibroblast - skin spinal muscular atrophy, donor1.CNhs11074.11555-120C7 | 487.40 | 46.76 | 1.29 | 1.10 | 0.18 |
Fibroblast - skin spinal muscular atrophy, donor2.CNhs11911.11558-120D1 | 1185.03 | 47.20 | 4.69 | 3.39 | 0.16 |
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction).CNhs12398.14305-155C3 | 679.84 | 34.44 | 1.07 | 0.71 | 0.00 |
Fibroblast - skin spinal muscular atrophy, donor3.CNhs11912.11559-120D2 | 623.55 | 61.66 | 2.72 | 1.11 | 0.20 |
Fibroblast - skin walker warburg, donor1.CNhs11352.11554-120C6 | 461.20 | 65.28 | 2.03 | 0.00 | 0.34 |
Gingival epithelial cells, donor1 (GEA11).CNhs11061.11221-116B6 | 258.20 | 47.93 | 0.77 | 0.58 | 0.58 |
Gingival epithelial cells, donor2 (GEA14).CNhs11896.11302-117B6 | 429.58 | 46.91 | 1.09 | 0.27 | 0.55 |
Gingival epithelial cells, donor3 (GEA15).CNhs11903.11379-118B2 | 566.73 | 50.76 | 0.86 | 0.29 | 0.29 |
H9 Embryonic Stem cells, biol_rep2 (H9ES-2).CNhs12824.12724-135G6 | 846.01 | 57.69 | 4.88 | 2.32 | 0.73 |
H9 Embryonic Stem cells, biol_rep3 (H9ES-3).CNhs12837.12822-136I5 | 548.28 | 49.30 | 3.98 | 2.12 | 0.53 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0).CNhs12822.12627-134E8 | 1054.69 | 69.25 | 6.27 | 1.86 | 1.74 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0).CNhs12825.12725-135G7 | 833.54 | 52.76 | 5.08 | 3.01 | 1.04 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0).CNhs12908.12823-136I6 | 620.71 | 77.71 | 5.30 | 3.03 | 1.01 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3).CNhs13738.13366-143F9 | 408.77 | 48.18 | 4.74 | 2.92 | 0.00 |
Hair Follicle Dermal Papilla Cells, donor1.CNhs12501.11271-116H2 | 952.78 | 90.74 | 0.00 | 3.13 | 0.00 |
Hair Follicle Dermal Papilla Cells, donor2.CNhs11979.11348-117G7 | 1177.13 | 95.84 | 10.94 | 4.50 | 0.00 |
Hair Follicle Dermal Papilla Cells, donor3.CNhs12030.11420-118F7 | 1317.81 | 111.89 | 11.05 | 2.76 | 0.00 |
Hair Follicle Outer Root Sheath Cells, donor1.CNhs12339.11504-119G1 | 573.03 | 66.40 | 4.18 | 0.46 | 0.00 |
Hair Follicle Outer Root Sheath Cells, donor2.CNhs12347.11584-120F9 | 464.17 | 83.02 | 7.22 | 1.44 | 0.72 |
Hep-2 cells mock treated, biol_rep1.CNhs13479.11898-125E8 | 449.09 | 63.41 | 5.56 | 2.25 | 0.95 |
Hep-2 cells mock treated, biol_rep2.CNhs13500.11899-125E9 | 682.43 | 73.67 | 4.21 | 2.02 | 0.17 |
Hep-2 cells mock treated, biol_rep3.CNhs13501.11900-125F1 | 734.84 | 60.98 | 2.17 | 1.93 | 1.21 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep1.CNhs13477.11890-125D9 | 499.08 | 70.37 | 5.62 | 2.54 | 0.66 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep2.CNhs13496.11891-125E1 | 604.40 | 65.80 | 3.05 | 0.65 | 1.09 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep3.CNhs13497.11892-125E2 | 562.57 | 67.62 | 1.42 | 0.95 | 0.71 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1.CNhs13478.11894-125E4 | 549.03 | 66.61 | 5.26 | 1.48 | 1.21 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2.CNhs13498.11895-125E5 | 565.71 | 72.60 | 4.12 | 1.37 | 0.59 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3.CNhs13499.11896-125E6 | 887.61 | 76.18 | 4.62 | 1.15 | 1.15 |
Hepatic Sinusoidal Endothelial Cells, donor1.CNhs12075.11521-119H9 | 1668.97 | 68.65 | 7.38 | 3.69 | 0.00 |
Hepatic Sinusoidal Endothelial Cells, donor2.CNhs12092.11601-120H8 | 2040.52 | 95.36 | 1.40 | 1.40 | 0.00 |
Hepatic Stellate Cells (lipocyte), donor1.CNhs11335.11524-119I3 | 772.11 | 83.55 | 2.88 | 1.65 | 1.23 |
Hepatic Stellate Cells (lipocyte), donor2.CNhs12093.11604-120I2 | 1642.09 | 110.26 | 1.47 | 4.41 | 4.41 |
Hepatocyte, donor1.CNhs12340.11523-119I2 | 428.43 | 58.31 | 2.54 | 1.27 | 1.27 |
Hepatocyte, donor2.CNhs12349.11603-120I1 | 273.23 | 65.85 | 0.00 | 0.00 | 0.00 |
Hepatocyte, donor3.CNhs12626.11684-122I1 | 487.99 | 62.62 | 0.59 | 1.77 | 0.59 |
Hodgkin's lymphoma cell line:HD-Mar2.CNhs11715.10435-106E3 | 357.14 | 52.98 | 6.18 | 1.32 | 0.44 |
Intestinal epithelial cells (polarized), donor1.CNhs10875.11246-116E4 | 348.55 | 31.61 | 0.74 | 1.84 | 2.46 |
Iris Pigment Epithelial Cells, donor1.CNhs12596.11530-119I9 | 821.12 | 64.51 | 1.54 | 1.37 | 0.17 |
Keratinocyte - epidermal, donor1.CNhs11064.11272-116H3 | 286.12 | 55.53 | 1.54 | 0.55 | 0.22 |
Keratinocyte - epidermal, donor2.CNhs11381.11349-117G8 | 834.02 | 80.93 | 0.00 | 0.00 | 0.00 |
Keratinocyte - epidermal, donor3.CNhs12031.11421-118F8 | 532.10 | 62.73 | 2.41 | 0.60 | 0.80 |
Keratinocyte - oral, donor1.CNhs10879.11251-116E9 | 391.56 | 52.78 | 1.39 | 1.20 | 0.46 |
Keratocytes, donor1.CNhs11337.11527-119I6 | 1004.47 | 171.70 | 1.30 | 0.33 | 0.98 |
Keratocytes, donor2.CNhs12095.11607-120I5 | 1866.68 | 100.87 | 2.08 | 2.08 | 3.12 |
Lens Epithelial Cells, donor1.CNhs12342.11529-119I8 | 535.47 | 73.61 | 2.89 | 4.33 | 0.00 |
Lens Epithelial Cells, donor2.CNhs12568.11609-120I7 | 1059.95 | 60.17 | 1.39 | 1.51 | 0.35 |
Lens Epithelial Cells, donor3.CNhs12572.11690-122I7 | 887.02 | 60.47 | 0.59 | 0.59 | 0.59 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1).CNhs11936.12260-130A1 | 670.15 | 68.43 | 1.15 | 0.87 | 0.58 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1).CNhs13157.12382-131E6 | 356.50 | 74.08 | 2.78 | 0.93 | 2.31 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 ).CNhs13276.12504-133A2 | 323.62 | 62.21 | 3.61 | 1.52 | 0.38 |
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2.CNhs12475.13097-140D1 | 2360.34 | 83.76 | 8.69 | 6.32 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3.CNhs12703.13163-141B4 | 2464.71 | 97.87 | 7.73 | 5.15 | 0.00 |
Macrophage - monocyte derived, donor1.CNhs10861.11232-116C8 | 304.32 | 109.57 | 1.48 | 0.74 | 0.00 |
Macrophage - monocyte derived, donor2.CNhs11899.11313-117C8 | 309.59 | 94.77 | 0.94 | 0.23 | 0.47 |
Macrophage - monocyte derived, donor3.CNhs12003.11389-118C3 | 427.02 | 114.59 | 1.63 | 1.78 | 1.19 |
Mallassez-derived cells, donor1 (MZH3).CNhs12538.12142-128E9 | 203.40 | 59.05 | 0.94 | 0.00 | 0.00 |
Mallassez-derived cells, donor2.CNhs13550.11929-125I3 | 294.81 | 62.99 | 0.84 | 1.34 | 0.00 |
Mallassez-derived cells, donor3.CNhs13551.11930-125I4 | 340.54 | 64.08 | 1.98 | 0.71 | 0.14 |
Mammary Epithelial Cell, donor1.CNhs11077.11273-116H4 | 540.66 | 54.00 | 2.06 | 0.63 | 0.09 |
Mammary Epithelial Cell, donor2.CNhs11382.11350-117G9 | 460.65 | 53.48 | 1.74 | 0.00 | 0.00 |
Mammary Epithelial Cell, donor3.CNhs12032.11422-118F9 | 1352.96 | 59.42 | 1.53 | 2.68 | 0.00 |
Mast cell - stimulated, donor1.CNhs11073.11487-119E2 | 943.94 | 129.57 | 0.99 | 0.49 | 0.00 |
Mast cell, donor1.CNhs12566.11563-120D6 | 701.22 | 109.97 | 1.14 | 1.67 | 0.18 |
Mast cell, donor2.CNhs12594.11565-120D8 | 744.93 | 102.63 | 1.87 | 8.29 | 0.62 |
Mast cell, donor3.CNhs12593.11566-120D9 | 675.20 | 107.80 | 1.44 | 5.76 | 0.00 |
Mast cell, donor4.CNhs12592.11567-120E1 | 706.07 | 106.55 | 1.26 | 5.55 | 0.00 |
Melanocyte - dark, donor3.CNhs12570.11663-122F7 | 430.90 | 45.34 | 0.83 | 0.83 | 0.32 |
Melanocyte - light, donor1.CNhs11303.11274-116H5 | 850.69 | 60.35 | 0.76 | 0.76 | 0.76 |
Melanocyte - light, donor2.CNhs11383.11351-117H1 | 696.27 | 46.89 | 0.00 | 0.00 | 1.17 |
Melanocyte - light, donor3.CNhs12033.11423-118G1 | 973.40 | 66.72 | 5.13 | 6.84 | 0.00 |
Melanocyte, donor1 (MC+1).CNhs12816.12641-134G4 | 270.23 | 32.39 | 3.19 | 1.54 | 0.31 |
Melanocyte, donor2 (MC+2).CNhs13156.12739-135I3 | 218.05 | 31.24 | 1.50 | 0.90 | 0.60 |
Melanocyte, donor3 (MC+3).CNhs13406.12837-137B2 | 642.82 | 53.45 | 2.00 | 2.00 | 0.29 |
Meningeal Cells, donor1.CNhs11320.11493-119E8 | 1373.27 | 83.20 | 1.35 | 0.45 | 1.23 |
Meningeal Cells, donor2.CNhs12080.11573-120E7 | 1700.68 | 57.98 | 1.31 | 1.31 | 0.44 |
Meningeal Cells, donor3.CNhs12731.11654-122E7 | 492.76 | 67.54 | 1.91 | 0.81 | 1.03 |
Mesenchymal Stem Cells - Wharton's Jelly, donor1.CNhs11057.11548-120B9 | 422.59 | 40.33 | 1.55 | 0.78 | 0.39 |
Mesenchymal Stem Cells - adipose, donor1.CNhs11345.11537-120A7 | 2181.70 | 278.97 | 3.58 | 7.15 | 0.00 |
Mesenchymal Stem Cells - adipose, donor3.CNhs12922.11698-123A6 | 359.25 | 79.46 | 1.69 | 0.85 | 2.54 |
Mesenchymal Stem Cells - amniotic membrane, donor1.CNhs11349.11547-120B8 | 638.78 | 44.41 | 1.60 | 0.80 | 0.27 |
Mesenchymal Stem Cells - amniotic membrane, donor2.CNhs12104.11627-122B7 | 1280.33 | 54.08 | 7.28 | 2.08 | 0.00 |
Mesenchymal Stem Cells - bone marrow, donor1.CNhs11344.11536-120A6 | 604.44 | 129.12 | 2.31 | 1.03 | 2.06 |
Mesenchymal Stem Cells - bone marrow, donor2.CNhs12100.11616-122A5 | 1309.27 | 97.88 | 5.67 | 1.42 | 0.00 |
Mesenchymal Stem Cells - bone marrow, donor3.CNhs12126.11697-123A5 | 913.03 | 136.14 | 2.13 | 1.33 | 2.66 |
Mesenchymal Stem Cells - hepatic, donor2.CNhs12730.11618-122A7 | 581.21 | 51.47 | 3.00 | 1.29 | 0.86 |
Mesenchymal Stem Cells - umbilical, donor1.CNhs11347.11539-120A9 | 1641.97 | 94.42 | 5.43 | 1.09 | 5.97 |
Mesenchymal Stem Cells - umbilical, donor3.CNhs12127.11700-123A8 | 1495.83 | 128.43 | 5.76 | 0.82 | 0.82 |
Mesenchymal stem cells - adipose, donor0.CNhs10844.11217-116B2 | 266.45 | 65.15 | 3.91 | 0.33 | 0.00 |
Mesenchymal stem cells - hepatic, donor0.CNhs10845.11218-116B3 | 651.08 | 52.24 | 1.78 | 2.13 | 0.00 |
Mesenchymal stem cells - umbilical, donor0.CNhs12492.11214-116A8 | 700.88 | 82.36 | 4.75 | 0.00 | 3.96 |
Mesothelial Cells, donor1.CNhs10850.11247-116E5 | 234.82 | 53.05 | 0.60 | 0.60 | 0.30 |
Mesothelial Cells, donor2.CNhs12197.12156-128G5 | 522.92 | 76.69 | 1.74 | 0.87 | 0.00 |
Mesothelial Cells, donor3.CNhs12012.11402-118D7 | 518.86 | 63.08 | 0.70 | 0.90 | 0.80 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h).CNhs13646.13317-143A5 | 363.66 | 116.76 | 1.22 | 0.00 | 1.22 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h).CNhs13650.13323-143B2 | 401.81 | 115.52 | 2.01 | 0.50 | 0.00 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h).CNhs13639.13311-142I8 | 381.61 | 132.83 | 8.43 | 6.33 | 0.00 |
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1.CNhs11350.11549-120C1 | 388.91 | 51.28 | 1.44 | 0.96 | 0.24 |
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2.CNhs12105.11629-122B9 | 1382.94 | 58.58 | 1.15 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day00, control donor1.CNhs13847.13469-144I4 | 2480.46 | 102.70 | 1.43 | 0.00 | 0.00 |
Myoblast, donor1.CNhs10870.11241-116D8 | 299.70 | 46.19 | 2.46 | 0.58 | 0.58 |
Myoblast, donor2.CNhs11965.11322-117D8 | 634.31 | 49.93 | 4.52 | 2.26 | 0.62 |
Myoblast, donor3.CNhs11908.11398-118D3 | 632.98 | 56.94 | 1.25 | 0.72 | 0.72 |
NK T cell leukemia cell line:KHYG-1.CNhs11867.10777-110G3 | 853.86 | 48.64 | 1.35 | 1.12 | 0.90 |
Natural Killer Cells, donor1.CNhs10859.11230-116C6 | 430.91 | 89.65 | 0.79 | 1.18 | 0.20 |
Natural Killer Cells, donor2.CNhs11957.11311-117C6 | 751.89 | 98.11 | 5.82 | 3.02 | 0.00 |
Natural Killer Cells, donor3.CNhs12001.11387-118C1 | 744.90 | 89.07 | 1.16 | 1.54 | 0.00 |
Neural stem cells, donor1.CNhs11063.11275-116H6 | 413.67 | 43.96 | 1.02 | 0.00 | 0.25 |
Neural stem cells, donor2.CNhs11384.11352-117H2 | 566.11 | 35.14 | 0.00 | 0.00 | 1.30 |
Neurons, donor1.CNhs12338.11494-119E9 | 511.14 | 23.97 | 2.32 | 1.55 | 0.00 |
Neurons, donor2.CNhs12726.11574-120E8 | 518.80 | 27.31 | 2.18 | 0.67 | 0.00 |
Neurons, donor3.CNhs13815.11655-122E8 | 545.44 | 22.97 | 7.02 | 5.74 | 0.00 |
Neutrophils, donor1.CNhs10862.11233-116C9 | 1173.69 | 387.99 | 4.49 | 6.74 | 163.28 |
Neutrophils, donor2.CNhs11959.11314-117C9 | 1585.56 | 556.44 | 2.99 | 8.97 | 77.78 |
Neutrophils, donor3.CNhs11905.11390-118C4 | 1657.66 | 476.58 | 0.83 | 0.41 | 127.23 |
Nucleus Pulposus Cell, donor1.CNhs10881.11252-116F1 | 825.22 | 64.66 | 2.33 | 0.98 | 1.59 |
Nucleus Pulposus Cell, donor2.CNhs12019.11409-118E5 | 1111.88 | 99.03 | 8.00 | 3.00 | 2.50 |
Nucleus Pulposus Cell, donor3.CNhs12063.11462-119B4 | 911.45 | 80.57 | 5.43 | 1.63 | 1.36 |
Olfactory epithelial cells, donor1.CNhs13816.11933-125I7 | 741.21 | 58.02 | 6.03 | 1.25 | 0.00 |
Olfactory epithelial cells, donor2.CNhs13817.11934-125I8 | 537.07 | 72.80 | 13.38 | 4.28 | 0.00 |
Olfactory epithelial cells, donor3.CNhs13818.11935-125I9 | 547.86 | 55.67 | 5.20 | 1.73 | 0.16 |
Olfactory epithelial cells, donor4.CNhs13819.11936-126A1 | 551.27 | 47.09 | 1.52 | 1.05 | 0.23 |
Osteoblast - differentiated, donor1.CNhs11311.11276-116H7 | 1170.38 | 71.02 | 3.31 | 3.31 | 0.60 |
Osteoblast - differentiated, donor2.CNhs11980.11353-117H3 | 825.49 | 75.04 | 9.10 | 6.82 | 0.00 |
Osteoblast - differentiated, donor3.CNhs12035.11425-118G3 | 1156.83 | 83.81 | 7.24 | 3.10 | 0.00 |
Osteoblast, donor2.CNhs11385.11354-117H4 | 435.73 | 63.10 | 1.99 | 0.00 | 1.33 |
Osteoblast, donor3.CNhs12036.11426-118G4 | 770.11 | 63.98 | 1.47 | 2.21 | 0.74 |
Pancreatic stromal cells, donor1.CNhs10877.11249-116E7 | 437.11 | 76.54 | 2.87 | 2.35 | 0.52 |
Pericytes, donor1.CNhs11317.11491-119E6 | 2476.10 | 124.92 | 2.74 | 4.11 | 1.37 |
Pericytes, donor2.CNhs12079.11571-120E5 | 2133.32 | 91.62 | 8.24 | 2.06 | 1.03 |
Peripheral Blood Mononuclear Cells, donor1.CNhs10860.11231-116C7 | 459.65 | 104.83 | 0.62 | 0.41 | 1.24 |
Peripheral Blood Mononuclear Cells, donor2.CNhs11958.11312-117C7 | 742.92 | 122.53 | 4.75 | 3.45 | 2.59 |
Peripheral Blood Mononuclear Cells, donor3.CNhs12002.11388-118C2 | 888.08 | 111.32 | 2.77 | 1.17 | 0.85 |
Placental Epithelial Cells, donor1.CNhs11079.11278-116H9 | 447.42 | 58.20 | 2.43 | 1.82 | 1.52 |
Placental Epithelial Cells, donor2.CNhs11386.11355-117H5 | 302.91 | 73.23 | 0.00 | 0.00 | 1.66 |
Placental Epithelial Cells, donor3.CNhs12037.11427-118G5 | 743.58 | 65.01 | 4.54 | 1.81 | 0.60 |
Preadipocyte - breast, donor1.CNhs11052.11467-119B9 | 221.06 | 42.67 | 2.98 | 0.74 | 0.74 |
Preadipocyte - breast, donor2 (nuclear fraction).CNhs12584.14320-155D9 | 389.95 | 26.40 | 0.92 | 0.15 | 0.15 |
Preadipocyte - breast, donor2.CNhs11971.11328-117E5 | 652.53 | 63.99 | 5.05 | 1.40 | 0.00 |
Preadipocyte - omental, donor1.CNhs11065.11468-119C1 | 342.77 | 41.77 | 1.92 | 0.64 | 0.77 |
Preadipocyte - omental, donor2.CNhs11902.11329-117E6 | 523.48 | 57.31 | 0.51 | 0.51 | 1.02 |
Preadipocyte - omental, donor3.CNhs12013.11403-118D8 | 533.55 | 49.86 | 1.29 | 0.48 | 0.97 |
Preadipocyte - perirenal, donor1.CNhs12065.11469-119C2 | 672.33 | 44.53 | 5.94 | 1.48 | 0.00 |
Preadipocyte - subcutaneous, donor2.CNhs11981.11356-117H6 | 667.73 | 80.03 | 3.08 | 1.54 | 0.77 |
Preadipocyte - subcutaneous, donor3.CNhs12038.11428-118G6 | 580.80 | 68.01 | 2.84 | 1.78 | 0.18 |
Preadipocyte - visceral, donor1.CNhs11082.11280-116I2 | 328.92 | 64.39 | 0.74 | 0.57 | 0.57 |
Preadipocyte - visceral, donor2.CNhs11982.11357-117H7 | 495.89 | 79.97 | 3.63 | 0.52 | 2.08 |
Preadipocyte - visceral, donor3.CNhs12039.11429-118G7 | 499.36 | 62.40 | 5.23 | 1.63 | 0.81 |
Prostate Epithelial Cells (polarized), donor1.CNhs10882.11253-116F2 | 367.65 | 31.18 | 3.14 | 2.54 | 2.18 |
Prostate Epithelial Cells, donor2.CNhs11972.11331-117E8 | 416.05 | 58.95 | 2.41 | 1.60 | 0.80 |
Prostate Epithelial Cells, donor3.CNhs12014.11404-118D9 | 516.57 | 114.64 | 2.03 | 1.66 | 0.64 |
Prostate Stromal Cells, donor1.CNhs10883.11254-116F3 | 286.46 | 64.53 | 2.64 | 1.72 | 1.26 |
Prostate Stromal Cells, donor2.CNhs11973.11332-117E9 | 716.71 | 84.85 | 4.92 | 1.64 | 0.73 |
Prostate Stromal Cells, donor3.CNhs12015.11405-118E1 | 705.58 | 77.63 | 3.28 | 3.93 | 0.39 |
Renal Cortical Epithelial Cells, donor1.CNhs11331.11516-119H4 | 1001.66 | 112.80 | 0.90 | 0.45 | 0.00 |
Renal Cortical Epithelial Cells, donor2.CNhs12728.11596-120H3 | 436.99 | 71.93 | 1.93 | 0.62 | 0.46 |
Renal Epithelial Cells, donor1.CNhs11332.11517-119H5 | 1258.10 | 187.46 | 3.14 | 0.78 | 1.57 |
Renal Epithelial Cells, donor2.CNhs12088.11597-120H4 | 1337.17 | 89.14 | 4.38 | 0.00 | 0.00 |
Renal Epithelial Cells, donor3.CNhs12732.11678-122H4 | 356.45 | 59.21 | 1.16 | 0.74 | 0.95 |
Renal Glomerular Endothelial Cells, donor1.CNhs12074.11514-119H2 | 1263.58 | 83.03 | 4.55 | 1.14 | 1.14 |
Renal Glomerular Endothelial Cells, donor2.CNhs12086.11594-120H1 | 732.25 | 71.61 | 5.44 | 2.55 | 0.85 |
Renal Glomerular Endothelial Cells, donor3.CNhs12624.11675-122H1 | 779.24 | 71.47 | 2.38 | 0.86 | 1.73 |
Renal Glomerular Endothelial Cells, donor4.CNhs13080.11783-124B1 | 1483.67 | 203.58 | 6.17 | 0.00 | 1.54 |
Renal Mesangial Cells, donor1.CNhs11333.11518-119H6 | 819.34 | 113.80 | 1.08 | 1.08 | 1.90 |
Renal Mesangial Cells, donor3.CNhs12121.11679-122H5 | 1532.66 | 147.00 | 4.52 | 3.51 | 0.50 |
Renal Proximal Tubular Epithelial Cell, donor1.CNhs11330.11515-119H3 | 377.22 | 112.91 | 0.76 | 0.00 | 1.27 |
Renal Proximal Tubular Epithelial Cell, donor2.CNhs12087.11595-120H2 | 1084.55 | 108.04 | 3.32 | 0.83 | 1.66 |
Renal Proximal Tubular Epithelial Cell, donor3.CNhs12120.11676-122H2 | 1026.24 | 119.10 | 0.90 | 1.79 | 0.67 |
Reticulocytes, biol_rep1.CNhs13552.11931-125I5 | 628.84 | 54.60 | 2.19 | 0.44 | 0.00 |
Reticulocytes, biol_rep2.CNhs13553.11932-125I6 | 442.09 | 50.46 | 3.14 | 0.26 | 0.00 |
Retinal Pigment Epithelial Cells, donor0.CNhs10842.11215-116A9 | 417.50 | 66.93 | 2.56 | 1.54 | 0.77 |
Retinal Pigment Epithelial Cells, donor1.CNhs11338.11528-119I7 | 740.99 | 68.23 | 2.62 | 0.98 | 0.33 |
Retinal Pigment Epithelial Cells, donor3.CNhs12733.11689-122I6 | 368.98 | 60.85 | 2.93 | 0.98 | 0.65 |
SABiosciences XpressRef Human Universal Total RNA, pool1.CNhs10610.10002-101A5 | 492.95 | 68.73 | 1.24 | 1.96 | 0.93 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0).CNhs12859.12760-136B6 | 649.59 | 43.13 | 2.38 | 1.47 | 0.55 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0).CNhs12952.12858-137D5 | 393.90 | 30.20 | 0.74 | 0.74 | 0.33 |
Sebocyte, donor1.CNhs10847.11220-116B5 | 438.74 | 70.63 | 0.00 | 1.15 | 0.57 |
Sebocyte, donor2.CNhs11951.11301-117B5 | 1072.60 | 77.36 | 1.95 | 0.65 | 0.00 |
Sertoli Cells, donor1.CNhs10851.11255-116F4 | 374.39 | 73.91 | 4.82 | 3.21 | 3.21 |
Skeletal Muscle Cells, donor1.CNhs11083.11281-116I3 | 665.00 | 92.03 | 3.09 | 1.93 | 0.29 |
Skeletal Muscle Cells, donor4.CNhs12053.11451-119A2 | 513.44 | 58.85 | 5.39 | 1.39 | 0.92 |
Skeletal Muscle Cells, donor5.CNhs12056.11455-119A6 | 538.64 | 57.87 | 4.76 | 3.38 | 0.15 |
Skeletal Muscle Cells, donor6.CNhs12060.11459-119B1 | 480.36 | 57.89 | 4.27 | 1.65 | 1.24 |
Skeletal Muscle Satellite Cells, donor1.CNhs10869.11240-116D7 | 513.47 | 65.42 | 3.12 | 2.04 | 1.29 |
Skeletal Muscle Satellite Cells, donor2.CNhs11964.11321-117D7 | 801.22 | 70.19 | 6.38 | 1.89 | 1.16 |
Skeletal Muscle Satellite Cells, donor3.CNhs12008.11397-118D2 | 713.77 | 60.00 | 2.90 | 1.19 | 0.51 |
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1.CNhs11084.11282-116I4 | 507.04 | 55.47 | 1.78 | 0.89 | 0.45 |
Small Airway Epithelial Cells, donor1.CNhs10884.11256-116F5 | 165.45 | 61.82 | 1.65 | 1.32 | 0.00 |
Small Airway Epithelial Cells, donor2.CNhs11975.11334-117F2 | 974.02 | 60.73 | 1.92 | 1.15 | 0.38 |
Small Airway Epithelial Cells, donor3 (nuclear fraction).CNhs12583.14317-155D6 | 261.48 | 21.82 | 0.51 | 0.13 | 0.00 |
Small Airway Epithelial Cells, donor3.CNhs12016.11406-118E2 | 999.84 | 97.21 | 1.21 | 1.21 | 0.71 |
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction).CNhs12401.14313-155D2 | 1307.61 | 121.32 | 12.55 | 3.72 | 0.93 |
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction).CNhs12402.14314-155D3 | 534.24 | 32.11 | 0.63 | 0.31 | 0.31 |
Smooth Muscle Cells - Aortic, donor0.CNhs10838.11210-116A4 | 524.17 | 73.19 | 0.70 | 0.70 | 1.39 |
Smooth Muscle Cells - Aortic, donor1.CNhs11085.11283-116I5 | 1088.59 | 62.22 | 2.77 | 0.31 | 0.31 |
Smooth Muscle Cells - Aortic, donor2.CNhs11305.11360-117I1 | 542.42 | 91.56 | 0.00 | 2.66 | 0.00 |
Smooth Muscle Cells - Aortic, donor3.CNhs11309.11432-118H1 | 615.04 | 85.25 | 0.87 | 0.00 | 1.74 |
Smooth Muscle Cells - Brachiocephalic, donor1.CNhs11086.11284-116I6 | 585.44 | 74.50 | 1.11 | 1.11 | 0.37 |
Smooth Muscle Cells - Brachiocephalic, donor3.CNhs12043.11433-118H2 | 182.77 | 24.47 | 0.00 | 1.00 | 0.14 |
Smooth Muscle Cells - Brain Vascular, donor1.CNhs10863.11234-116D1 | 458.13 | 46.52 | 1.49 | 1.86 | 0.37 |
Smooth Muscle Cells - Brain Vascular, donor2.CNhs11900.11315-117D1 | 513.80 | 47.14 | 0.95 | 0.32 | 0.32 |
Smooth Muscle Cells - Brain Vascular, donor3.CNhs12004.11391-118C5 | 604.87 | 61.95 | 2.48 | 1.14 | 1.72 |
Smooth Muscle Cells - Bronchial, donor1.CNhs11328.11512-119G9 | 747.22 | 180.15 | 2.05 | 1.28 | 1.79 |
Smooth Muscle Cells - Bronchial, donor2.CNhs12348.11592-120G8 | 904.66 | 106.56 | 2.57 | 2.14 | 0.00 |
Smooth Muscle Cells - Carotid, donor1.CNhs11087.11285-116I7 | 900.52 | 70.64 | 2.23 | 2.23 | 0.64 |
Smooth Muscle Cells - Carotid, donor3.CNhs12044.11434-118H3 | 989.82 | 91.84 | 2.35 | 10.20 | 2.35 |
Smooth Muscle Cells - Colonic, donor1.CNhs10868.11239-116D6 | 301.47 | 69.79 | 1.62 | 1.08 | 0.90 |
Smooth Muscle Cells - Colonic, donor2.CNhs11963.11320-117D6 | 698.70 | 75.50 | 4.39 | 0.82 | 1.37 |
Smooth Muscle Cells - Colonic, donor3.CNhs12007.11396-118D1 | 660.10 | 79.29 | 3.18 | 1.65 | 0.71 |
Smooth Muscle Cells - Coronary Artery, donor1.CNhs11088.11286-116I8 | 515.97 | 80.27 | 1.01 | 1.01 | 0.61 |
Smooth Muscle Cells - Coronary Artery, donor2.CNhs11987.11363-117I4 | 640.38 | 68.16 | 0.00 | 1.59 | 1.59 |
Smooth Muscle Cells - Coronary Artery, donor3.CNhs12045.11435-118H4 | 424.21 | 50.13 | 1.26 | 2.95 | 0.42 |
Smooth Muscle Cells - Esophageal, donor1.CNhs11324.11508-119G5 | 1108.39 | 146.78 | 2.44 | 0.00 | 3.41 |
Smooth Muscle Cells - Internal Thoracic Artery, donor2.CNhs11988.11364-117I5 | 375.56 | 83.11 | 2.19 | 0.49 | 0.97 |
Smooth Muscle Cells - Internal Thoracic Artery, donor3.CNhs12046.11436-118H5 | 553.61 | 75.01 | 5.28 | 4.23 | 0.00 |
Smooth Muscle Cells - Prostate, donor1.CNhs11920.11257-116F6 | 759.21 | 56.37 | 2.05 | 1.91 | 0.27 |
Smooth Muscle Cells - Prostate, donor2.CNhs11976.11335-117F3 | 899.34 | 74.38 | 3.68 | 1.70 | 1.27 |
Smooth Muscle Cells - Pulmonary Artery, donor2.CNhs11989.11365-117I6 | 789.93 | 65.54 | 3.39 | 0.00 | 0.00 |
Smooth Muscle Cells - Subclavian Artery, donor1.CNhs11090.11289-117A2 | 587.76 | 70.57 | 3.86 | 2.21 | 1.65 |
Smooth Muscle Cells - Subclavian Artery, donor2.CNhs11990.11366-117I7 | 506.87 | 90.23 | 4.64 | 0.66 | 0.66 |
Smooth Muscle Cells - Subclavian Artery, donor3.CNhs12048.11438-118H7 | 456.43 | 62.70 | 2.19 | 0.88 | 0.44 |
Smooth Muscle Cells - Tracheal, donor1.CNhs11329.11513-119H1 | 571.83 | 119.23 | 1.16 | 0.00 | 2.32 |
Smooth Muscle Cells - Tracheal, donor3.CNhs12894.11674-122G9 | 857.25 | 106.25 | 4.59 | 1.31 | 1.97 |
Smooth Muscle Cells - Umbilical Artery, donor1.CNhs11091.11290-117A3 | 501.59 | 79.74 | 0.61 | 1.42 | 1.62 |
Smooth Muscle Cells - Umbilical Artery, donor2.CNhs11991.11367-117I8 | 882.69 | 82.72 | 2.48 | 3.72 | 0.93 |
Smooth Muscle Cells - Umbilical Artery, donor3.CNhs12049.11439-118H8 | 862.55 | 70.42 | 3.38 | 3.38 | 0.28 |
Smooth Muscle Cells - Umbilical Vein, donor1.CNhs12597.11541-120B2 | 858.32 | 95.66 | 2.15 | 1.15 | 0.72 |
Smooth Muscle Cells - Umbilical Vein, donor2.CNhs12569.11621-122B1 | 652.18 | 63.86 | 1.47 | 0.88 | 1.28 |
Smooth Muscle Cells - Umbilical artery, donor0.CNhs10839.11212-116A6 | 591.72 | 84.89 | 2.14 | 1.43 | 1.43 |
Smooth Muscle Cells - Uterine, donor3.CNhs11927.11466-119B8 | 549.52 | 75.21 | 1.06 | 0.71 | 1.42 |
Synoviocyte, donor2.CNhs11992.11368-117I9 | 769.91 | 77.27 | 5.07 | 3.17 | 0.84 |
Synoviocyte, donor3.CNhs12050.11440-118H9 | 771.87 | 64.54 | 6.26 | 1.98 | 0.00 |
Trabecular Meshwork Cells, donor1.CNhs11340.11532-120A2 | 1423.78 | 130.92 | 1.52 | 1.14 | 2.66 |
Trabecular Meshwork Cells, donor3.CNhs12124.11693-123A1 | 1451.53 | 155.37 | 1.40 | 2.10 | 2.45 |
Tracheal Epithelial Cells, donor1.CNhs11092.11292-117A5 | 313.20 | 56.10 | 0.29 | 0.67 | 0.48 |
Tracheal Epithelial Cells, donor2.CNhs11993.11369-118A1 | 922.34 | 76.41 | 0.67 | 1.34 | 0.00 |
Tracheal Epithelial Cells, donor3.CNhs12051.11441-118I1 | 789.46 | 58.80 | 3.27 | 3.27 | 1.09 |
Universal RNA - Human Normal Tissues Biochain, pool1.CNhs10612.10007-101B4 | 456.60 | 65.90 | 1.22 | 2.73 | 1.41 |
Urothelial Cells, donor1.CNhs11334.11520-119H8 | 502.40 | 89.11 | 1.29 | 0.43 | 0.43 |
Urothelial Cells, donor2.CNhs12091.11600-120H7 | 818.77 | 70.76 | 6.74 | 0.00 | 1.68 |
Urothelial Cells, donor3.CNhs12122.11681-122H7 | 756.05 | 92.68 | 1.33 | 0.89 | 0.00 |
Urothelial cells, donor0.CNhs10843.11216-116B1 | 267.63 | 43.42 | 1.38 | 0.92 | 0.46 |
Whole blood (ribopure), donor090309, donation1.CNhs11675.12179-129A1 | 2144.98 | 147.16 | 5.58 | 2.03 | 22.84 |
Whole blood (ribopure), donor090309, donation2.CNhs11671.12180-129A2 | 1797.66 | 169.75 | 6.88 | 3.06 | 21.41 |
Whole blood (ribopure), donor090309, donation3.CNhs11948.12181-129A3 | 2496.76 | 191.97 | 11.96 | 6.27 | 23.93 |
Whole blood (ribopure), donor090325, donation1.CNhs11075.12176-128I7 | 853.35 | 131.98 | 1.43 | 1.67 | 16.44 |
Whole blood (ribopure), donor090325, donation2.CNhs11076.12177-128I8 | 513.79 | 137.81 | 2.88 | 0.82 | 20.98 |
Whole blood (ribopure), donor090612, donation1.CNhs11672.12182-129A4 | 1566.06 | 167.31 | 2.59 | 1.30 | 30.48 |
Whole blood (ribopure), donor090612, donation2.CNhs11673.12183-129A5 | 2029.98 | 118.81 | 2.70 | 3.24 | 23.22 |
Whole blood (ribopure), donor090612, donation3.CNhs11949.12184-129A6 | 2469.00 | 172.11 | 13.48 | 4.76 | 23.00 |
Wilms' tumor cell line:G-401.CNhs11892.10809-111A8 | 1084.48 | 55.87 | 1.60 | 1.18 | 0.53 |
Wilms' tumor cell line:HFWT.CNhs11728.10597-108E3 | 1527.46 | 102.02 | 0.00 | 0.00 | 1.92 |
acantholytic squamous carcinoma cell line:HCC1806.CNhs11844.10717-109I6 | 700.57 | 53.17 | 1.23 | 1.47 | 0.74 |
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1.CNhs11251.10455-106G5 | 682.46 | 68.93 | 1.30 | 0.93 | 0.74 |
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6.CNhs11282.10534-107G3 | 438.29 | 77.18 | 1.59 | 0.58 | 3.03 |
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL.CNhs10746.10429-106D6 | 610.25 | 60.54 | 1.00 | 0.71 | 0.36 |
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat.CNhs11253.10464-106H5 | 304.34 | 62.81 | 1.43 | 0.00 | 1.43 |
acute myeloid leukemia (FAB M0) cell line:KG-1.CNhs13053.10827-111C8 | 290.39 | 55.28 | 1.40 | 1.20 | 0.40 |
acute myeloid leukemia (FAB M0) cell line:Kasumi-3.CNhs13241.10789-110H6 | 198.59 | 114.33 | 1.72 | 0.19 | 0.96 |
acute myeloid leukemia (FAB M1) cell line:HYT-1.CNhs13054.10828-111C9 | 783.19 | 87.21 | 1.69 | 1.48 | 0.64 |
acute myeloid leukemia (FAB M2) cell line:Kasumi-1.CNhs13502.10788-110H5 | 751.50 | 71.09 | 2.27 | 1.30 | 0.97 |
acute myeloid leukemia (FAB M2) cell line:Kasumi-6.CNhs13052.10792-110H9 | 468.65 | 107.55 | 0.84 | 0.00 | 0.00 |
acute myeloid leukemia (FAB M2) cell line:NKM-1.CNhs11864.10765-110E9 | 681.97 | 79.43 | 1.60 | 1.14 | 0.00 |
acute myeloid leukemia (FAB M3) cell line:HL60.CNhs13055.10829-111D1 | 508.27 | 163.26 | 2.19 | 1.10 | 5.80 |
acute myeloid leukemia (FAB M4) cell line:FKH-1.CNhs13503.10830-111D2 | 521.32 | 70.18 | 2.51 | 0.00 | 2.51 |
acute myeloid leukemia (FAB M4) cell line:HNT-34.CNhs13504.10831-111D3 | 377.18 | 105.47 | 2.54 | 1.02 | 2.54 |
acute myeloid leukemia (FAB M4eo) cell line:EoL-1.CNhs13056.10832-111D4 | 416.73 | 93.94 | 0.48 | 0.48 | 1.61 |
acute myeloid leukemia (FAB M4eo) cell line:EoL-3.CNhs13057.10833-111D5 | 477.66 | 101.91 | 1.82 | 1.41 | 1.82 |
acute myeloid leukemia (FAB M5) cell line:NOMO-1.CNhs13050.10764-110E8 | 898.11 | 129.03 | 0.43 | 1.70 | 0.85 |
acute myeloid leukemia (FAB M5) cell line:P31/FUJ.CNhs13051.10770-110F5 | 308.81 | 107.86 | 0.34 | 1.72 | 1.72 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh).CNhs10722.10399-106A3 | 620.32 | 128.43 | 0.92 | 0.00 | 3.07 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived).CNhs10723.10400-106A4 | 584.47 | 134.43 | 0.89 | 0.00 | 3.36 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed).CNhs10724.10405-106A9 | 515.06 | 130.31 | 0.33 | 0.33 | 2.17 |
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4.CNhs13058.10834-111D6 | 472.84 | 114.30 | 1.95 | 0.78 | 4.49 |
acute myeloid leukemia (FAB M6) cell line:EEB.CNhs13059.10835-111D7 | 1281.78 | 64.03 | 1.11 | 0.84 | 1.67 |
acute myeloid leukemia (FAB M6) cell line:F-36E.CNhs13060.10836-111D8 | 1866.00 | 102.16 | 0.00 | 0.00 | 1.23 |
acute myeloid leukemia (FAB M6) cell line:F-36P.CNhs13505.10837-111D9 | 442.47 | 78.16 | 2.43 | 1.08 | 0.54 |
acute myeloid leukemia (FAB M7) cell line:M-MOK.CNhs13049.10699-109G6 | 1149.10 | 83.60 | 0.67 | 0.00 | 0.33 |
acute myeloid leukemia (FAB M7) cell line:MKPL-1.CNhs11888.10802-111A1 | 2871.91 | 159.32 | 0.00 | 0.00 | 2.82 |
adenocarcinoma cell line:IM95m.CNhs11882.10796-110I4 | 850.93 | 56.89 | 0.56 | 0.19 | 1.12 |
adipose tissue, adult, pool1.CNhs10615.10010-101C1 | 335.36 | 77.06 | 2.64 | 2.78 | 0.44 |
adrenal cortex adenocarcinoma cell line:SW-13.CNhs11893.10810-111A9 | 1738.61 | 54.25 | 0.61 | 0.97 | 2.55 |
adult T-cell leukemia cell line:ATN-1.CNhs10738.10421-106C7 | 745.22 | 98.85 | 1.78 | 0.67 | 0.45 |
alveolar cell carcinoma cell line:SW 1573.CNhs11838.10708-109H6 | 983.40 | 61.66 | 2.56 | 1.70 | 1.14 |
amniotic membrane cells, donor1.CNhs12502.12235-129G3 | 419.00 | 20.77 | 0.95 | 1.43 | 0.00 |
amniotic membrane cells, donor2.CNhs12503.12236-129G4 | 465.34 | 28.81 | 2.38 | 3.56 | 0.59 |
amniotic membrane cells, donor3.CNhs12379.12237-129G5 | 598.66 | 25.80 | 0.61 | 0.31 | 0.61 |
amygdala - adult, donor10196.CNhs13793.10167-103B5 | 404.62 | 105.38 | 2.98 | 0.00 | 0.00 |
amygdala, adult, donor10252.CNhs12311.10151-102I7 | 927.01 | 65.69 | 1.13 | 0.28 | 0.42 |
anaplastic carcinoma cell line:8305C.CNhs10745.10428-106D5 | 704.58 | 49.20 | 1.45 | 0.11 | 0.22 |
anaplastic large cell lymphoma cell line:Ki-JK.CNhs11881.10795-110I3 | 841.16 | 44.00 | 2.14 | 1.15 | 1.65 |
anaplastic squamous cell carcinoma cell line:RPMI 2650.CNhs11889.10805-111A4 | 1269.07 | 35.89 | 1.06 | 2.11 | 0.42 |
aorta, adult, pool1.CNhs11760.10052-101G7 | 1090.68 | 67.35 | 1.59 | 2.59 | 0.60 |
appendix, adult.CNhs12842.10189-103D9 | 704.52 | 80.95 | 0.55 | 0.83 | 0.28 |
argyrophil small cell carcinoma cell line:TC-YIK.CNhs11725.10589-108D4 | 767.39 | 37.29 | 1.26 | 0.76 | 0.00 |
astrocytoma cell line:TM-31.CNhs10742.10425-106D2 | 339.84 | 39.78 | 0.82 | 0.31 | 0.10 |
b cell line:RPMI1788.CNhs10744.10427-106D4 | 617.39 | 81.36 | 1.35 | 0.49 | 0.12 |
basal cell carcinoma cell line:TE 354.T.CNhs11932.10702-109G9 | 342.14 | 59.10 | 0.93 | 0.31 | 0.31 |
bile duct carcinoma cell line:HuCCT1.CNhs10750.10432-106D9 | 618.92 | 37.65 | 0.63 | 0.27 | 0.63 |
bile duct carcinoma cell line:TFK-1.CNhs11265.10496-107C1 | 503.77 | 60.87 | 1.07 | 1.43 | 1.61 |
biphenotypic B myelomonocytic leukemia cell line:MV-4-11.CNhs11845.10718-109I7 | 888.60 | 80.83 | 2.56 | 1.53 | 1.02 |
bladder, adult, pool1.CNhs10616.10011-101C2 | 572.82 | 83.26 | 1.09 | 1.58 | 0.59 |
blood, adult, pool1.CNhs11761.10053-101G8 | 2349.33 | 112.56 | 7.18 | 7.18 | 7.18 |
bone marrow stromal cell line:StromaNKtert.CNhs11931.10686-109F2 | 1401.44 | 82.24 | 0.00 | 0.00 | 0.00 |
brain, adult, donor1.CNhs11796.10084-102B3 | 429.41 | 44.59 | 1.94 | 3.88 | 0.97 |
brain, adult, pool1.CNhs10617.10012-101C3 | 442.04 | 115.96 | 0.93 | 1.02 | 0.56 |
brain, fetal, pool1.CNhs11797.10085-102B4 | 794.46 | 19.96 | 2.00 | 0.00 | 0.00 |
breast carcinoma cell line:MCF7.CNhs11943.10482-107A5 | 3869.44 | 67.97 | 1.82 | 2.86 | 1.56 |
breast carcinoma cell line:MDA-MB-453.CNhs10736.10419-106C5 | 970.63 | 52.48 | 0.26 | 0.26 | 0.09 |
breast, adult, donor1.CNhs11792.10080-102A8 | 1399.97 | 62.35 | 1.45 | 2.90 | 0.00 |
bronchial squamous cell carcinoma cell line:KNS-62.CNhs11862.10760-110E4 | 824.32 | 60.88 | 2.39 | 1.02 | 0.46 |
bronchioalveolar carcinoma cell line:NCI-H358.CNhs11840.10709-109H7 | 1019.05 | 49.58 | 0.76 | 0.76 | 1.27 |
bronchogenic carcinoma cell line:ChaGo-K-1.CNhs11841.10710-109H8 | 800.17 | 44.68 | 1.42 | 0.24 | 1.42 |
carcinoid cell line:NCI-H1770.CNhs11834.10703-109H1 | 618.47 | 37.92 | 3.45 | 2.07 | 0.00 |
carcinoid cell line:SK-PN-DW.CNhs11846.10719-109I8 | 1276.64 | 44.03 | 4.37 | 0.58 | 0.29 |
carcinosarcoma cell line:JHUCS-1.CNhs11747.10642-109A3 | 819.86 | 38.72 | 4.69 | 1.56 | 0.17 |
caudate nucleus - adult, donor10196.CNhs13802.10177-103C6 | 557.13 | 87.69 | 1.77 | 1.77 | 0.00 |
caudate nucleus, adult, donor10252.CNhs12321.10164-103B2 | 763.13 | 70.31 | 0.60 | 0.72 | 0.36 |
cerebellum - adult, donor10196.CNhs13799.10173-103C2 | 927.70 | 54.93 | 0.00 | 1.53 | 0.00 |
cerebellum, adult, donor10252.CNhs12323.10166-103B4 | 1154.78 | 42.02 | 1.44 | 1.22 | 0.66 |
cerebellum, adult, pool1.CNhs11795.10083-102B2 | 751.87 | 35.47 | 2.96 | 1.18 | 0.30 |
cerebral meninges, adult.CNhs12840.10188-103D8 | 489.89 | 98.28 | 0.66 | 2.41 | 0.22 |
cervical cancer cell line:D98-AH2.CNhs11288.10552-107I3 | 655.92 | 20.48 | 0.54 | 0.87 | 0.22 |
cervical cancer cell line:ME-180.CNhs11289.10553-107I4 | 566.90 | 33.46 | 1.39 | 0.42 | 0.28 |
cervix, adult, pool1.CNhs10618.10013-101C4 | 493.71 | 58.94 | 1.23 | 2.39 | 0.15 |
cholangiocellular carcinoma cell line:HuH-28.CNhs11283.10536-107G5 | 378.74 | 19.26 | 1.60 | 0.68 | 0.00 |
choriocarcinoma cell line:T3M-3.CNhs11820.10618-108G6 | 1745.83 | 48.65 | 0.69 | 0.69 | 0.92 |
choriocarcinoma cell line:BeWo.CNhs10740.10423-106C9 | 545.37 | 50.89 | 2.33 | 1.08 | 0.63 |
choriocarcinoma cell line:SCH.CNhs11875.10785-110H2 | 1388.30 | 37.81 | 1.30 | 0.65 | 0.54 |
chorionic membrane cells, donor1.CNhs12504.12238-129G6 | 432.57 | 41.79 | 1.91 | 1.28 | 1.28 |
chorionic membrane cells, donor2.CNhs12506.12239-129G7 | 436.00 | 41.86 | 1.47 | 2.38 | 0.27 |
chorionic membrane cells, donor3.CNhs12380.12240-129G8 | 877.38 | 58.10 | 3.73 | 3.73 | 0.53 |
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3.CNhs11714.10416-106C2 | 407.75 | 89.93 | 18.39 | 3.07 | 1.02 |
chronic myeloblastic leukemia (CML) cell line:KCL-22.CNhs11886.10801-110I9 | 884.90 | 66.87 | 1.88 | 1.41 | 0.78 |
chronic myelogenous leukemia (CML) cell line:MEG-A2.CNhs11865.10766-110F1 | 720.20 | 87.59 | 0.50 | 0.66 | 0.66 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1.CNhs12334.10824-111C5 | 832.22 | 106.48 | 1.58 | 0.23 | 5.19 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2.CNhs12335.10825-111C6 | 852.48 | 95.29 | 0.98 | 0.39 | 4.12 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3.CNhs12336.10826-111C7 | 786.92 | 98.68 | 1.17 | 0.34 | 2.69 |
chronic myelogenous leukemia cell line:K562.CNhs11250.10454-106G4 | 247.25 | 50.09 | 1.14 | 0.38 | 1.71 |
chronic myelogenous leukemia cell line:KU812.CNhs10727.10409-106B4 | 621.44 | 52.77 | 0.32 | 0.32 | 0.64 |
clear cell carcinoma cell line:JHOC-5.CNhs11745.10638-108I8 | 501.12 | 99.59 | 4.43 | 2.32 | 1.48 |
clear cell carcinoma cell line:TEN.CNhs11930.10636-108I6 | 1112.43 | 49.95 | 2.45 | 1.14 | 2.94 |
colon carcinoma cell line:CACO-2.CNhs11280.10513-107D9 | 454.73 | 29.26 | 0.42 | 1.13 | 3.39 |
colon carcinoma cell line:COLO-320.CNhs10737.10420-106C6 | 810.81 | 46.74 | 1.08 | 0.00 | 0.22 |
colon, adult, donor1.CNhs11794.10082-102B1 | 612.09 | 57.73 | 1.99 | 1.00 | 0.00 |
colon, adult, pool1.CNhs10619.10014-101C5 | 412.74 | 61.65 | 0.71 | 2.74 | 1.33 |
colon, fetal, donor1.CNhs11780.10070-101I7 | 927.54 | 64.77 | 2.44 | 3.06 | 0.61 |
cord blood derived cell line:COBL-a 24h infection(-C).CNhs11049.10452-106G2 | 317.28 | 35.29 | 0.30 | 0.30 | 0.30 |
cord blood derived cell line:COBL-a 24h infection.CNhs11050.10453-106G3 | 401.71 | 49.18 | 1.98 | 0.62 | 0.00 |
cord blood derived cell line:COBL-a untreated.CNhs11045.10449-106F8 | 582.36 | 50.75 | 0.84 | 0.73 | 0.31 |
corpus callosum, adult, pool1.CNhs10649.10042-101F6 | 399.08 | 61.00 | 0.40 | 0.54 | 0.20 |
diaphragm, fetal, donor1.CNhs11779.10069-101I6 | 849.93 | 26.49 | 0.00 | 0.00 | 0.00 |
diencephalon, adult.CNhs12610.10193-103E4 | 550.99 | 75.43 | 0.70 | 1.17 | 0.23 |
diffuse large B-cell lymphoma cell line:CTB-1.CNhs11741.10631-108I1 | 1042.18 | 150.71 | 11.49 | 3.28 | 1.28 |
ductal cell carcinoma cell line:KLM-1.CNhs11100.10438-106E6 | 555.49 | 78.66 | 0.20 | 0.78 | 0.98 |
ductal cell carcinoma cell line:MIA Paca2.CNhs11259.10488-107B2 | 749.46 | 19.18 | 0.97 | 0.97 | 0.49 |
ductus deferens, adult.CNhs12846.10196-103E7 | 583.20 | 59.19 | 0.39 | 2.37 | 0.00 |
duodenum, fetal, donor1, tech_rep1.CNhs11781.10071-101I8 | 544.46 | 41.14 | 4.84 | 1.21 | 0.00 |
temporal lobe, fetal, donor1, tech_rep2.CNhs12996.10063-101H9 | 665.40 | 24.18 | 3.06 | 1.53 | 0.00 |
dura mater, adult, donor1.CNhs10648.10041-101F5 | 613.67 | 109.50 | 1.26 | 1.14 | 0.63 |
embryonic kidney cell line: HEK293/SLAM infection, 24hr.CNhs11047.10451-106G1 | 356.42 | 25.25 | 1.65 | 0.90 | 0.90 |
embryonic kidney cell line: HEK293/SLAM untreated.CNhs11046.10450-106F9 | 425.02 | 47.39 | 1.56 | 0.62 | 0.41 |
embryonic pancreas cell line:1B2C6.CNhs11731.10604-108F1 | 1686.89 | 73.11 | 0.66 | 0.66 | 0.66 |
embryonic pancreas cell line:1C3D3.CNhs11732.10605-108F2 | 844.69 | 80.43 | 2.32 | 1.32 | 1.99 |
embryonic pancreas cell line:1C3IKEI.CNhs11733.10606-108F3 | 1340.81 | 68.44 | 0.94 | 0.31 | 1.57 |
embryonic pancreas cell line:2C6.CNhs11814.10603-108E9 | 2450.38 | 118.28 | 0.00 | 1.19 | 1.19 |
endometrial carcinoma cell line:OMC-2.CNhs11266.10497-107C2 | 773.00 | 107.01 | 0.28 | 0.00 | 1.14 |
endometrial stromal sarcoma cell line:OMC-9.CNhs11249.10448-106F7 | 302.45 | 59.77 | 1.94 | 0.42 | 1.39 |
endometrioid adenocarcinoma cell line:JHUEM-1.CNhs11748.10643-109A4 | 473.47 | 59.70 | 4.17 | 2.26 | 0.00 |
epidermoid carcinoma cell line:A431.CNhs10743.10426-106D3 | 591.09 | 35.67 | 0.10 | 0.39 | 0.78 |
epidermoid carcinoma cell line:Ca Ski.CNhs10748.10431-106D8 | 592.18 | 53.72 | 0.26 | 0.52 | 0.96 |
epididymis, adult.CNhs12847.10197-103E8 | 557.90 | 80.55 | 1.57 | 2.45 | 0.35 |
epithelioid sarcoma cell line:HS-ES-1.CNhs11247.10443-106F2 | 516.47 | 52.63 | 1.55 | 0.52 | 1.20 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1.CNhs12325.10815-111B5 | 1388.65 | 64.73 | 4.55 | 2.03 | 0.29 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2.CNhs12326.10816-111B6 | 1564.33 | 56.13 | 2.19 | 1.10 | 0.37 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3.CNhs12327.10817-111B7 | 1370.75 | 66.51 | 3.28 | 1.48 | 0.74 |
esophagus, adult, pool1.CNhs10620.10015-101C6 | 361.67 | 73.23 | 2.13 | 2.04 | 0.39 |
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS.CNhs10728.10410-106B5 | 1287.39 | 73.43 | 0.88 | 0.71 | 3.53 |
eye, fetal, donor1.CNhs11762.10054-101G9 | 1092.84 | 45.42 | 2.03 | 1.58 | 0.23 |
fibrosarcoma cell line:HT-1080.CNhs11860.10758-110E2 | 879.12 | 30.42 | 1.64 | 1.23 | 0.27 |
fibrous histiocytoma cell line:GCT TIB-223.CNhs11842.10711-109H9 | 760.28 | 78.69 | 1.59 | 0.60 | 1.39 |
frontal lobe, adult, pool1.CNhs10647.10040-101F4 | 246.79 | 61.47 | 0.57 | 0.13 | 0.19 |
gall bladder carcinoma cell line:TGBC14TKB.CNhs11256.10470-106I2 | 446.83 | 44.78 | 1.96 | 0.59 | 1.17 |
gall bladder carcinoma cell line:TGBC2TKB.CNhs10733.10415-106C1 | 346.13 | 77.03 | 0.40 | 0.08 | 1.20 |
gall bladder, adult.CNhs12848.10198-103E9 | 569.92 | 70.87 | 1.71 | 3.42 | 0.00 |
gastric adenocarcinoma cell line:MKN1.CNhs11737.10614-108G2 | 763.47 | 30.77 | 5.79 | 2.40 | 0.60 |
gastric adenocarcinoma cell line:MKN45.CNhs11819.10612-108F9 | 1342.78 | 68.01 | 1.44 | 1.01 | 0.72 |
gastric cancer cell line:AZ521.CNhs11286.10549-107H9 | 573.03 | 26.46 | 0.80 | 0.23 | 2.06 |
gastrointestinal carcinoma cell line:ECC12.CNhs11738.10615-108G3 | 2316.70 | 65.21 | 8.58 | 4.29 | 1.72 |
giant cell carcinoma cell line:LU65.CNhs11274.10487-107B1 | 198.36 | 17.72 | 1.73 | 1.30 | 0.14 |
giant cell carcinoma cell line:Lu99B.CNhs10751.10433-106E1 | 731.97 | 49.45 | 0.75 | 0.62 | 0.37 |
glassy cell carcinoma cell line:HOKUG.CNhs11824.10688-109F4 | 1032.81 | 53.03 | 0.94 | 0.71 | 0.00 |
glioblastoma cell line:A172, tech_rep2.CNhs11248.10444-106F3 | 344.25 | 39.14 | 0.27 | 0.00 | 0.27 |
glioblastoma cell line:A172.CNhs11185.10444-106F3 | 352.30 | 42.36 | 0.42 | 0.73 | 1.15 |
glioblastoma cell line:T98G.CNhs11272.10485-107A8 | 220.01 | 45.08 | 0.10 | 0.10 | 0.71 |
glioma cell line:GI-1.CNhs10731.10413-106B8 | 1012.48 | 45.65 | 0.58 | 0.58 | 1.16 |
globus pallidus - adult, donor10196.CNhs13801.10175-103C4 | 592.61 | 93.07 | 0.00 | 0.60 | 0.00 |
globus pallidus, adult, donor10252.CNhs12319.10161-103A8 | 784.33 | 77.49 | 0.41 | 0.55 | 0.00 |
granulocyte macrophage progenitor, donor1.CNhs12519.12131-128D7 | 917.22 | 15.33 | 0.00 | 0.00 | 0.00 |
granulosa cell tumor cell line:KGN.CNhs11740.10624-108H3 | 684.19 | 46.41 | 2.15 | 1.72 | 1.29 |
hairy cell leukemia cell line:Mo.CNhs11843.10712-109I1 | 707.69 | 93.59 | 0.79 | 0.79 | 0.53 |
heart - mitral valve, adult.CNhs12855.10205-103F7 | 568.90 | 48.32 | 0.84 | 1.95 | 0.00 |
heart - pulmonic valve, adult.CNhs12856.10206-103F8 | 614.15 | 54.31 | 1.15 | 0.92 | 0.69 |
heart - tricuspid valve, adult.CNhs12857.10207-103F9 | 811.91 | 56.71 | 0.00 | 0.72 | 0.00 |
heart, adult, diseased post-infarction, donor1.CNhs11757.10050-101G5 | 1088.25 | 65.69 | 2.40 | 1.20 | 0.20 |
heart, adult, diseased, donor1.CNhs11758.10051-101G6 | 1182.09 | 78.12 | 2.58 | 1.29 | 0.00 |
heart, adult, pool1.CNhs10621.10016-101C7 | 532.49 | 75.66 | 0.89 | 2.01 | 0.89 |
heart, fetal, pool1.CNhs10653.10046-101G1 | 523.22 | 31.64 | 0.54 | 0.40 | 0.67 |
hepatic mesenchymal tumor cell line:LI90.CNhs11868.10778-110G4 | 1074.41 | 46.48 | 1.80 | 0.72 | 0.00 |
hepatoblastoma cell line:HuH-6.CNhs11742.10633-108I3 | 3941.06 | 58.25 | 1.16 | 0.00 | 3.49 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1.CNhs12328.10818-111B8 | 1196.56 | 39.00 | 1.81 | 1.10 | 1.73 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2.CNhs12329.10819-111B9 | 1060.77 | 39.31 | 1.40 | 0.82 | 2.23 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3.CNhs12330.10820-111C1 | 1149.90 | 39.70 | 1.55 | 0.61 | 2.22 |
hepatoma cell line:Li-7.CNhs11271.10484-107A7 | 611.83 | 69.59 | 2.17 | 1.38 | 1.38 |
hereditary spherocytic anemia cell line:WIL2-NS.CNhs11891.10808-111A7 | 1350.96 | 55.80 | 0.76 | 0.76 | 0.68 |
hippocampus - adult, donor10196.CNhs13795.10169-103B7 | 474.75 | 106.56 | 0.80 | 0.00 | 1.59 |
hippocampus, adult, donor10252.CNhs12312.10153-102I9 | 955.60 | 62.38 | 1.36 | 1.09 | 0.54 |
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2.CNhs13822.13425-144D5 | 380.18 | 52.08 | 7.56 | 1.93 | 1.29 |
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1.CNhs13826.13433-144E4 | 469.15 | 44.15 | 6.74 | 6.33 | 0.83 |
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2.CNhs13839.13437-144E8 | 587.43 | 44.45 | 25.34 | 5.82 | 0.42 |
immature langerhans cells, donor1.CNhs13537.11904-125F5 | 532.51 | 123.51 | 2.25 | 0.90 | 0.90 |
immature langerhans cells, donor2.CNhs13480.11905-125F6 | 384.58 | 64.23 | 2.32 | 0.77 | 0.00 |
insula, adult, pool1.CNhs10646.10039-101F3 | 215.17 | 66.89 | 0.61 | 0.24 | 0.06 |
keratoacanthoma cell line:HKA-1.CNhs11880.10791-110H8 | 640.68 | 26.16 | 2.35 | 1.34 | 0.34 |
kidney, adult, pool1.CNhs10622.10017-101C8 | 426.65 | 60.92 | 0.32 | 1.18 | 2.29 |
kidney, fetal, pool1.CNhs10652.10045-101F9 | 580.04 | 51.41 | 1.00 | 0.26 | 1.15 |
large cell lung carcinoma cell line:IA-LM.CNhs11277.10509-107D5 | 574.04 | 67.69 | 0.42 | 0.32 | 0.53 |
large cell lung carcinoma cell line:NCI-H460.CNhs12806.10839-111E2 | 1131.84 | 34.06 | 11.47 | 3.94 | 0.72 |
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF.CNhs11825.10692-109F8 | 906.03 | 75.23 | 0.38 | 0.19 | 0.58 |
left atrium, adult, donor1.CNhs11790.10079-102A7 | 1281.45 | 60.03 | 4.29 | 5.72 | 1.43 |
left ventricle, adult, donor1.CNhs11789.10078-102A6 | 1109.00 | 74.15 | 1.99 | 1.99 | 1.99 |
leiomyoblastoma cell line:G-402.CNhs11848.10721-110A1 | 1447.55 | 55.18 | 0.51 | 0.76 | 1.53 |
leiomyoma cell line:10964C.CNhs11722.10569-108B2 | 449.06 | 89.59 | 7.60 | 2.71 | 0.54 |
leiomyoma cell line:15242A.CNhs11723.10570-108B3 | 331.86 | 89.01 | 5.19 | 2.59 | 1.73 |
leiomyoma cell line:15425.CNhs11724.10571-108B4 | 378.19 | 104.51 | 5.23 | 3.92 | 1.63 |
lens epithelial cell line:SRA 01/04.CNhs11750.10647-109A8 | 897.98 | 58.67 | 2.39 | 2.39 | 0.00 |
leukemia, chronic megakaryoblastic cell line:MEG-01.CNhs11859.10752-110D5 | 834.55 | 65.43 | 0.33 | 0.57 | 0.90 |
liposarcoma cell line:KMLS-1.CNhs11870.10782-110G8 | 778.16 | 40.72 | 1.19 | 0.68 | 1.02 |
liposarcoma cell line:SW 872.CNhs11851.10726-110A6 | 675.00 | 55.86 | 0.68 | 1.02 | 0.57 |
liver, adult, pool1.CNhs10624.10018-101C9 | 684.11 | 92.77 | 1.32 | 4.10 | 0.44 |
liver, fetal, pool1.CNhs11798.10086-102B5 | 1474.80 | 53.00 | 2.65 | 3.98 | 1.33 |
locus coeruleus - adult, donor10196.CNhs13808.10182-103D2 | 506.27 | 86.49 | 0.52 | 0.90 | 0.65 |
locus coeruleus, adult, donor10252.CNhs12322.10165-103B3 | 740.37 | 71.54 | 0.66 | 0.40 | 0.13 |
lung adenocarcinoma cell line:A549.CNhs11275.10499-107C4 | 1071.69 | 71.00 | 0.00 | 0.34 | 2.22 |
lung adenocarcinoma cell line:PC-14.CNhs10726.10408-106B3 | 1117.13 | 84.58 | 0.00 | 0.00 | 3.52 |
lung, adult, pool1.CNhs10625.10019-101D1 | 579.11 | 91.09 | 1.71 | 4.06 | 2.67 |
lung, fetal, donor1.CNhs11680.10068-101I5 | 606.81 | 52.82 | 0.79 | 0.63 | 3.14 |
lung, right lower lobe, adult, donor1.CNhs11786.10075-102A3 | 809.84 | 90.30 | 2.49 | 1.66 | 1.24 |
lymph node, adult, donor1.CNhs11788.10077-102A5 | 888.14 | 107.17 | 3.97 | 2.98 | 3.47 |
lymphangiectasia cell line:DS-1.CNhs11852.10727-110A7 | 862.38 | 44.27 | 1.38 | 1.19 | 0.00 |
lymphoma, malignant, hairy B-cell cell line:MLMA.CNhs11935.10775-110G1 | 875.08 | 96.83 | 0.85 | 0.49 | 1.83 |
malignant trichilemmal cyst cell line:DJM-1.CNhs10730.10412-106B7 | 808.14 | 74.05 | 0.00 | 0.00 | 0.64 |
mature adipocyte, donor1.CNhs12558.12231-129F8 | 903.61 | 60.39 | 0.00 | 1.63 | 0.00 |
mature adipocyte, donor2.CNhs12559.12232-129F9 | 875.16 | 53.65 | 0.00 | 2.51 | 0.00 |
mature adipocyte, donor3.CNhs12560.12233-129G1 | 760.96 | 78.73 | 0.61 | 1.23 | 0.00 |
mature adipocyte, donor4.CNhs12562.12234-129G2 | 684.27 | 87.54 | 1.64 | 0.98 | 0.33 |
maxillary sinus tumor cell line:HSQ-89.CNhs10732.10414-106B9 | 1886.06 | 62.98 | 0.63 | 0.47 | 1.26 |
medial frontal gyrus - adult, donor10196.CNhs13796.10170-103B8 | 472.27 | 98.35 | 0.89 | 0.00 | 0.00 |
medial temporal gyrus - adult, donor10196.CNhs13809.10183-103D3 | 334.23 | 96.52 | 5.37 | 1.34 | 0.24 |
medial temporal gyrus, adult, donor10252.CNhs12310.10150-102I6 | 957.21 | 71.61 | 0.38 | 0.25 | 0.00 |
medulla oblongata - adult, donor10196.CNhs13800.10174-103C3 | 587.74 | 82.00 | 2.29 | 1.15 | 0.00 |
medulla oblongata, adult, donor10252.CNhs12315.10155-103A2 | 905.29 | 68.33 | 0.78 | 1.00 | 0.67 |
medulla oblongata, adult, pool1.CNhs10645.10038-101F2 | 321.97 | 74.58 | 0.37 | 0.50 | 1.24 |
medulloblastoma cell line:D283 Med.CNhs12805.10838-111E1 | 888.47 | 26.15 | 6.23 | 1.52 | 0.97 |
medulloblastoma cell line:ONS-76.CNhs11861.10759-110E3 | 1170.32 | 69.86 | 0.37 | 0.25 | 0.50 |
melanoma cell line:COLO 679.CNhs11281.10514-107E1 | 353.34 | 41.86 | 1.97 | 1.36 | 1.52 |
melanoma cell line:G-361.CNhs11254.10465-106H6 | 407.64 | 54.24 | 1.71 | 2.28 | 0.57 |
meningioma cell line:HKBMM.CNhs11945.10691-109F7 | 474.30 | 73.40 | 8.23 | 4.00 | 0.00 |
merkel cell carcinoma cell line:MKL-1.CNhs12838.10843-111E6 | 680.02 | 29.97 | 3.28 | 2.34 | 0.00 |
merkel cell carcinoma cell line:MS-1.CNhs12839.10844-111E7 | 466.94 | 28.69 | 2.75 | 2.17 | 0.00 |
mesenchymal precursor cell - adipose, donor1.CNhs12363.11747-123G1 | 730.45 | 59.70 | 3.13 | 1.34 | 0.45 |
mesenchymal precursor cell - adipose, donor2.CNhs12364.11748-123G2 | 837.86 | 51.88 | 2.34 | 0.93 | 0.23 |
mesenchymal precursor cell - adipose, donor3.CNhs12365.11749-123G3 | 838.87 | 57.70 | 3.33 | 1.66 | 0.00 |
mesenchymal precursor cell - bone marrow, donor1.CNhs12366.11750-123G4 | 993.99 | 56.25 | 2.46 | 0.76 | 0.00 |
mesenchymal precursor cell - bone marrow, donor2.CNhs12367.11751-123G5 | 935.33 | 44.02 | 3.27 | 1.76 | 0.25 |
mesenchymal precursor cell - bone marrow, donor3.CNhs13098.11840-124H4 | 164.62 | 64.07 | 1.78 | 0.89 | 0.89 |
mesenchymal precursor cell - cardiac, donor1.CNhs12368.11752-123G6 | 752.43 | 56.52 | 3.20 | 2.29 | 0.23 |
mesenchymal precursor cell - cardiac, donor2.CNhs12369.11753-123G7 | 907.23 | 49.30 | 4.69 | 1.97 | 0.30 |
mesenchymal precursor cell - cardiac, donor3.CNhs12370.11754-123G8 | 705.53 | 50.52 | 3.89 | 1.09 | 0.16 |
mesenchymal precursor cell - cardiac, donor4.CNhs12371.11755-123G9 | 559.04 | 54.11 | 2.07 | 1.63 | 0.89 |
mesenchymal precursor cell - ovarian cancer left ovary, donor1.CNhs12372.11756-123H1 | 735.31 | 47.31 | 1.91 | 1.12 | 0.80 |
mesenchymal precursor cell - ovarian cancer left ovary, donor2.CNhs13092.11833-124G6 | 394.93 | 80.96 | 3.15 | 1.35 | 0.90 |
mesenchymal precursor cell - ovarian cancer left ovary, donor3.CNhs12376.11760-123H5 | 769.95 | 57.60 | 1.71 | 0.93 | 0.00 |
mesenchymal precursor cell - ovarian cancer left ovary, donor4.CNhs13094.11836-124G9 | 307.71 | 74.65 | 1.66 | 0.41 | 1.66 |
mesenchymal precursor cell - ovarian cancer metastasis, donor1.CNhs12374.11758-123H3 | 724.95 | 49.45 | 4.52 | 0.80 | 0.27 |
mesenchymal precursor cell - ovarian cancer metastasis, donor2.CNhs13093.11835-124G8 | 293.74 | 55.30 | 1.57 | 0.52 | 0.52 |
mesenchymal precursor cell - ovarian cancer metastasis, donor3.CNhs12378.11762-123H7 | 885.77 | 64.61 | 2.70 | 2.25 | 0.45 |
mesenchymal precursor cell - ovarian cancer metastasis, donor4.CNhs13097.11838-124H2 | 177.07 | 47.98 | 2.67 | 1.52 | 0.76 |
mesenchymal precursor cell - ovarian cancer right ovary, donor1.CNhs12373.11757-123H2 | 519.98 | 62.66 | 2.44 | 0.41 | 0.00 |
mesenchymal precursor cell - ovarian cancer right ovary, donor2.CNhs12375.11759-123H4 | 689.75 | 48.01 | 2.91 | 1.09 | 0.18 |
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02).CNhs12377.11761-123H6 | 808.69 | 52.31 | 3.44 | 1.07 | 0.21 |
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G).CNhs13507.11842-124H6 | 625.05 | 55.68 | 1.39 | 2.78 | 0.00 |
mesenchymal precursor cell - ovarian cancer right ovary, donor4.CNhs13096.11837-124H1 | 210.99 | 40.61 | 1.99 | 0.80 | 0.00 |
mesenchymal stem cell line:Hu5/E18.CNhs11718.10568-108B1 | 503.63 | 64.80 | 7.20 | 2.40 | 0.40 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2.CNhs13420.13230-141I8 | 494.83 | 70.74 | 1.03 | 2.75 | 1.03 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3.CNhs13421.13231-141I9 | 539.47 | 69.03 | 3.70 | 0.67 | 1.01 |
mesodermal tumor cell line:HIRS-BM.CNhs12191.10696-109G3 | 1487.72 | 87.07 | 0.00 | 0.00 | 2.52 |
mesothelioma cell line:ACC-MESO-1.CNhs11263.10493-107B7 | 538.57 | 52.01 | 0.96 | 0.39 | 0.19 |
mesothelioma cell line:ACC-MESO-4.CNhs11264.10494-107B8 | 485.50 | 35.60 | 0.64 | 0.00 | 0.64 |
mesothelioma cell line:Mero-25.CNhs13066.10850-111F4 | 920.53 | 78.56 | 4.44 | 1.30 | 0.52 |
mesothelioma cell line:Mero-41.CNhs13067.10851-111F5 | 706.87 | 107.69 | 2.72 | 1.13 | 0.00 |
mesothelioma cell line:Mero-48a.CNhs13068.10852-111F6 | 504.02 | 78.02 | 0.93 | 0.69 | 1.39 |
mesothelioma cell line:Mero-82.CNhs13069.10853-111F7 | 661.03 | 42.58 | 1.47 | 1.96 | 1.71 |
mesothelioma cell line:Mero-83.CNhs13070.10854-111F8 | 504.85 | 30.62 | 1.61 | 1.43 | 0.00 |
mesothelioma cell line:Mero-84.CNhs13072.10855-111F9 | 472.78 | 84.61 | 3.40 | 0.31 | 2.78 |
mesothelioma cell line:Mero-95.CNhs13073.10856-111G1 | 427.60 | 50.22 | 2.41 | 0.88 | 1.32 |
mesothelioma cell line:NCI-H2052.CNhs13063.10847-111F1 | 708.70 | 73.86 | 1.06 | 0.18 | 1.24 |
mesothelioma cell line:NCI-H226.CNhs13062.10846-111E9 | 688.90 | 117.29 | 2.12 | 0.39 | 1.35 |
mesothelioma cell line:NCI-H2452.CNhs13064.10848-111F2 | 597.72 | 90.72 | 1.18 | 1.35 | 1.01 |
mesothelioma cell line:NCI-H28.CNhs13061.10845-111E8 | 571.67 | 61.24 | 3.59 | 1.28 | 1.28 |
mesothelioma cell line:No36.CNhs13074.10857-111G2 | 390.34 | 48.36 | 1.73 | 1.04 | 1.04 |
mesothelioma cell line:ONE58.CNhs13075.10858-111G3 | 401.10 | 61.08 | 3.95 | 0.91 | 0.61 |
middle temporal gyrus, donor10252.CNhs12316.10156-103A3 | 1035.00 | 71.62 | 0.55 | 0.14 | 0.41 |
migratory langerhans cells, donor1.CNhs13535.11901-125F2 | 609.52 | 158.42 | 0.97 | 1.36 | 0.58 |
migratory langerhans cells, donor2.CNhs13536.11902-125F3 | 411.62 | 120.64 | 1.59 | 0.80 | 1.33 |
migratory langerhans cells, donor3.CNhs13547.11903-125F4 | 666.37 | 124.80 | 0.49 | 1.14 | 0.00 |
mixed mullerian tumor cell line:HTMMT.CNhs11944.10689-109F5 | 679.14 | 89.44 | 8.85 | 3.60 | 1.31 |
mucinous adenocarcinoma cell line:JHOM-1.CNhs11752.10648-109A9 | 603.37 | 99.05 | 6.14 | 1.47 | 0.25 |
mucinous cystadenocarcinoma cell line:MCAS.CNhs11873.10784-110H1 | 1714.80 | 34.66 | 0.42 | 0.00 | 0.21 |
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162.CNhs11858.10744-110C6 | 726.15 | 76.00 | 3.00 | 1.80 | 0.20 |
myelodysplastic syndrome cell line:SKM-1.CNhs11934.10772-110F7 | 443.52 | 42.25 | 0.85 | 0.43 | 1.39 |
myeloma cell line:PCM6.CNhs11258.10474-106I6 | 379.22 | 125.37 | 2.24 | 0.34 | 0.17 |
myxofibrosarcoma cell line:MFH-ino.CNhs11729.10600-108E6 | 1852.37 | 83.42 | 0.57 | 0.00 | 0.57 |
myxofibrosarcoma cell line:NMFH-1.CNhs11821.10684-109E9 | 1258.55 | 83.03 | 0.92 | 0.55 | 0.92 |
nasal epithelial cells, donor1, tech_rep1.CNhs12589.12226-129F3 | 446.64 | 67.70 | 0.70 | 0.56 | 0.28 |
nasal epithelial cells, donor2.CNhs12574.12227-129F4 | 767.02 | 46.03 | 4.35 | 1.87 | 0.00 |
neuroblastoma cell line:CHP-134.CNhs11276.10508-107D4 | 1111.53 | 33.51 | 0.26 | 0.26 | 0.13 |
neuroblastoma cell line:NB-1.CNhs11284.10539-107G8 | 666.36 | 33.10 | 0.75 | 0.22 | 0.22 |
neuroblastoma cell line:NBsusSR.CNhs11818.10607-108F4 | 1208.12 | 45.92 | 2.83 | 2.52 | 0.63 |
neuroblastoma cell line:NH-12.CNhs11811.10555-107I6 | 2548.52 | 21.41 | 3.06 | 0.76 | 0.00 |
neuroectodermal tumor cell line:TASK1.CNhs11866.10774-110F9 | 591.01 | 25.80 | 0.85 | 0.34 | 0.00 |
neuroectodermal tumor cell line:FU-RPNT-1.CNhs11744.10637-108I7 | 2466.29 | 38.69 | 9.57 | 2.55 | 0.43 |
neuroectodermal tumor cell line:FU-RPNT-2.CNhs11753.10663-109C6 | 2226.63 | 53.17 | 10.66 | 5.58 | 0.37 |
neuroepithelioma cell line:SK-N-MC.CNhs11853.10728-110A8 | 3230.08 | 76.53 | 0.00 | 0.56 | 1.12 |
neurofibroma cell line:Hs 53.T.CNhs11854.10729-110A9 | 983.59 | 47.06 | 0.32 | 0.32 | 0.00 |
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK.CNhs10747.10430-106D7 | 412.37 | 40.30 | 1.26 | 0.47 | 0.79 |
non-small cell lung cancer cell line:NCI-H1385.CNhs12193.10730-110B1 | 920.66 | 86.46 | 0.80 | 3.20 | 1.60 |
normal embryonic palatal mesenchymal cell line:HEPM.CNhs11894.10813-111B3 | 617.18 | 43.03 | 2.82 | 4.23 | 1.06 |
normal intestinal epithelial cell line:FHs 74 Int.CNhs11950.10812-111B2 | 515.72 | 65.23 | 6.74 | 0.92 | 0.31 |
nucleus accumbens, adult, pool1.CNhs10644.10037-101F1 | 290.70 | 59.80 | 0.64 | 0.19 | 0.19 |
occipital cortex - adult, donor10196.CNhs13798.10172-103C1 | 636.22 | 106.27 | 0.00 | 0.00 | 0.00 |
occipital cortex, adult, donor10252.CNhs12320.10163-103B1 | 1116.48 | 62.74 | 0.48 | 0.16 | 0.32 |
occipital lobe, adult, donor1.CNhs11787.10076-102A4 | 414.95 | 69.12 | 0.41 | 2.26 | 0.21 |
occipital lobe, fetal, donor1.CNhs11784.10073-102A1 | 780.92 | 20.67 | 2.27 | 2.02 | 0.00 |
occipital pole, adult, pool1.CNhs10643.10036-101E9 | 410.79 | 84.10 | 0.35 | 0.48 | 0.41 |
olfactory region, adult.CNhs12611.10195-103E6 | 698.22 | 92.85 | 0.48 | 0.65 | 0.00 |
optic nerve, donor1.CNhs13449.10277-104E7 | 549.66 | 88.52 | 0.00 | 1.43 | 0.00 |
oral squamous cell carcinoma cell line:Ca9-22.CNhs10752.10434-106E2 | 404.27 | 23.46 | 0.10 | 0.59 | 0.10 |
oral squamous cell carcinoma cell line:HO-1-u-1.CNhs11287.10550-107I1 | 377.27 | 44.71 | 0.59 | 0.12 | 0.12 |
oral squamous cell carcinoma cell line:HSC-3.CNhs11717.10545-107H5 | 679.97 | 62.37 | 4.59 | 2.93 | 0.73 |
oral squamous cell carcinoma cell line:SAS.CNhs11810.10544-107H4 | 1922.46 | 37.89 | 2.66 | 2.19 | 0.35 |
osteoclastoma cell line:Hs 706.T.CNhs11835.10704-109H2 | 814.63 | 60.26 | 0.76 | 0.76 | 0.38 |
osteosarcoma cell line:143B/TK^(-)neo^(R).CNhs11279.10510-107D6 | 806.34 | 40.04 | 0.00 | 0.00 | 1.38 |
osteosarcoma cell line:HS-Os-1.CNhs11290.10558-107I9 | 472.23 | 26.65 | 0.80 | 1.19 | 0.60 |
ovary, adult, pool1.CNhs10626.10020-101D2 | 672.68 | 65.66 | 1.13 | 3.16 | 0.98 |
pagetoid sarcoma cell line:Hs 925.T.CNhs11856.10732-110B3 | 1323.79 | 66.56 | 2.42 | 0.40 | 0.81 |
pancreas, adult, donor1.CNhs11756.10049-101G4 | 1027.69 | 44.55 | 2.34 | 0.78 | 0.00 |
pancreatic carcinoma cell line:NOR-P1.CNhs11832.10698-109G5 | 1282.82 | 46.62 | 2.62 | 1.57 | 0.52 |
papillary adenocarcinoma cell line:8505C.CNhs11716.10437-106E5 | 356.86 | 36.03 | 3.28 | 0.98 | 0.49 |
papillotubular adenocarcinoma cell line:TGBC18TKB.CNhs10734.10417-106C3 | 726.42 | 49.24 | 1.03 | 0.59 | 1.18 |
paracentral gyrus, adult, pool1.CNhs10642.10035-101E8 | 302.57 | 67.27 | 0.41 | 0.74 | 0.41 |
parietal lobe - adult, donor10196.CNhs13797.10171-103B9 | 415.53 | 88.26 | 0.78 | 1.56 | 0.78 |
parietal lobe, adult, donor10252.CNhs12317.10157-103A4 | 1019.79 | 63.04 | 0.21 | 0.62 | 0.00 |
parietal lobe, adult, pool1.CNhs10641.10034-101E7 | 352.97 | 69.63 | 0.44 | 0.13 | 0.38 |
parietal lobe, fetal, donor1.CNhs11782.10072-101I9 | 1048.55 | 17.50 | 3.83 | 3.28 | 0.00 |
parotid gland, adult.CNhs12849.10199-103F1 | 914.49 | 64.69 | 1.64 | 2.74 | 0.00 |
penis, adult.CNhs12850.10200-103F2 | 489.26 | 52.60 | 4.47 | 3.47 | 0.00 |
peripheral neuroectodermal tumor cell line:KU-SN.CNhs11830.10697-109G4 | 692.05 | 44.85 | 1.93 | 1.41 | 0.18 |
pharyngeal carcinoma cell line:Detroit 562.CNhs11849.10723-110A3 | 641.75 | 55.96 | 1.15 | 0.51 | 0.26 |
pineal gland - adult, donor10196.CNhs13804.10179-103C8 | 776.23 | 107.68 | 0.54 | 0.54 | 1.07 |
pineal gland, adult, donor10252.CNhs12228.10160-103A7 | 1015.24 | 59.52 | 0.34 | 0.00 | 1.01 |
pituitary gland - adult, donor10196.CNhs13805.10180-103C9 | 420.02 | 80.12 | 2.43 | 1.82 | 1.21 |
pituitary gland, adult, donor10252.CNhs12229.10162-103A9 | 683.21 | 46.22 | 0.46 | 0.23 | 0.23 |
placenta, adult, pool1.CNhs10627.10021-101D3 | 358.09 | 64.84 | 0.35 | 0.35 | 0.71 |
plasma cell leukemia cell line:ARH-77.CNhs12807.10840-111E3 | 599.56 | 75.82 | 4.03 | 0.92 | 0.81 |
pleomorphic hepatocellular carcinoma cell line:SNU-387.CNhs11933.10706-109H4 | 1193.90 | 36.53 | 1.37 | 0.86 | 0.51 |
pons, adult, pool1.CNhs10640.10033-101E6 | 334.21 | 69.67 | 0.54 | 0.41 | 0.75 |
postcentral gyrus, adult, pool1.CNhs10638.10032-101E5 | 284.14 | 75.38 | 0.72 | 0.86 | 0.46 |
prostate cancer cell line:DU145.CNhs11260.10490-107B4 | 516.15 | 52.01 | 1.30 | 0.47 | 0.95 |
prostate cancer cell line:PC-3.CNhs11243.10439-106E7 | 484.97 | 41.16 | 0.78 | 0.22 | 0.78 |
prostate, adult, pool1.CNhs10628.10022-101D4 | 414.13 | 65.46 | 1.41 | 0.71 | 0.47 |
putamen, adult, donor10196.CNhs12324.10176-103C5 | 649.20 | 85.00 | 1.89 | 1.10 | 0.16 |
rectal cancer cell line:TT1TKB.CNhs11255.10469-106I1 | 871.65 | 33.63 | 0.28 | 0.28 | 1.40 |
rectum, fetal, donor1.CNhs11777.10067-101I4 | 569.81 | 27.39 | 1.83 | 0.00 | 0.91 |
renal cell carcinoma cell line:OS-RC-2.CNhs10729.10411-106B6 | 396.01 | 96.74 | 0.65 | 0.22 | 0.65 |
renal cell carcinoma cell line:TUHR10TKB.CNhs11257.10471-106I3 | 327.26 | 66.41 | 0.96 | 0.48 | 6.21 |
retina, adult, pool1.CNhs10636.10030-101E3 | 545.72 | 67.12 | 1.43 | 0.29 | 0.29 |
retinoblastoma cell line:Y79.CNhs11267.10475-106I7 | 673.61 | 31.44 | 1.58 | 0.95 | 0.00 |
rhabdomyosarcoma cell line:KYM-1.CNhs11877.10787-110H4 | 1168.58 | 50.80 | 0.93 | 0.70 | 1.28 |
rhabdomyosarcoma cell line:RMS-YM.CNhs11269.10477-106I9 | 1256.47 | 53.03 | 0.35 | 0.00 | 1.39 |
sacrococcigeal teratoma cell line:HTST.CNhs11829.10695-109G2 | 2060.40 | 91.40 | 0.00 | 0.00 | 2.41 |
salivary acinar cells, donor1.CNhs12810.11771-123I7 | 903.26 | 41.24 | 3.94 | 1.45 | 0.21 |
salivary acinar cells, donor2.CNhs12811.11772-123I8 | 597.34 | 43.87 | 5.98 | 1.71 | 0.17 |
salivary acinar cells, donor3.CNhs12812.11773-123I9 | 2021.93 | 64.29 | 0.69 | 0.69 | 0.69 |
salivary gland, adult, pool1.CNhs11677.10093-102C3 | 607.05 | 61.09 | 0.00 | 1.29 | 0.43 |
schwannoma cell line:HS-PSS, tech_rep2.CNhs11245.10442-106F1 | 480.55 | 86.50 | 1.89 | 0.59 | 0.12 |
schwannoma cell line:HS-PSS.CNhs11183.10442-106F1 | 429.65 | 89.64 | 1.11 | 0.60 | 0.34 |
seminal vesicle, adult.CNhs12851.10201-103F3 | 413.23 | 101.61 | 1.69 | 3.39 | 0.42 |
serous adenocarcinoma cell line:JHOS-2.CNhs11746.10639-108I9 | 431.87 | 33.68 | 4.81 | 1.60 | 0.46 |
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1.CNhs13508.11843-124H7 | 900.53 | 52.42 | 2.79 | 1.55 | 0.31 |
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1.CNhs13099.11841-124H5 | 242.71 | 65.93 | 5.73 | 1.91 | 0.00 |
serous cystadenocarcinoma cell line:HTOA.CNhs11827.10693-109F9 | 861.17 | 42.95 | 1.79 | 1.12 | 3.36 |
signet ring carcinoma cell line:Kato III.CNhs10753.10436-106E4 | 841.44 | 84.61 | 1.57 | 1.47 | 1.37 |
signet ring carcinoma cell line:NUGC-4.CNhs11270.10483-107A6 | 541.07 | 94.12 | 1.34 | 0.73 | 1.71 |
skeletal muscle - soleus muscle, donor1.CNhs13454.10282-104F3 | 399.46 | 86.76 | 0.00 | 0.00 | 0.65 |
skeletal muscle, adult, pool1.CNhs10629.10023-101D5 | 391.04 | 67.04 | 0.21 | 2.26 | 1.95 |
skeletal muscle, fetal, donor1.CNhs11776.10066-101I3 | 1058.91 | 29.00 | 1.16 | 2.32 | 0.00 |
skin, fetal, donor1.CNhs11774.10065-101I2 | 516.31 | 36.91 | 1.94 | 3.40 | 0.00 |
small cell cervical cancer cell line:HCSC-1.CNhs11885.10800-110I8 | 1119.17 | 53.34 | 2.34 | 1.40 | 0.23 |
small cell gastrointestinal carcinoma cell line:ECC10.CNhs11736.10610-108F7 | 583.32 | 32.83 | 2.98 | 0.60 | 0.40 |
small cell lung carcinoma cell line:DMS 144.CNhs12808.10841-111E4 | 500.30 | 38.41 | 3.21 | 0.95 | 1.55 |
small cell lung carcinoma cell line:LK-2.CNhs11285.10541-107H1 | 1200.28 | 58.96 | 0.90 | 1.36 | 0.45 |
small cell lung carcinoma cell line:NCI-H82.CNhs12809.10842-111E5 | 900.85 | 56.73 | 4.07 | 2.42 | 0.44 |
small cell lung carcinoma cell line:WA-hT.CNhs11812.10562-108A4 | 1053.42 | 46.19 | 0.91 | 0.91 | 0.75 |
small intestine, adult, pool1.CNhs10630.10024-101D6 | 458.11 | 76.02 | 1.08 | 2.32 | 4.09 |
small intestine, fetal, donor1.CNhs11773.10064-101I1 | 1061.33 | 74.53 | 2.62 | 1.97 | 1.53 |
small-cell gastrointestinal carcinoma cell line:ECC4.CNhs11734.10609-108F6 | 335.81 | 69.14 | 6.58 | 0.94 | 0.47 |
smooth muscle, adult, pool1.CNhs11755.10048-101G3 | 677.59 | 56.14 | 1.96 | 1.72 | 0.25 |
somatostatinoma cell line:QGP-1.CNhs11869.10781-110G7 | 1832.62 | 95.45 | 0.00 | 0.24 | 1.65 |
spinal cord - adult, donor10196.CNhs13807.10181-103D1 | 654.89 | 82.65 | 1.57 | 1.77 | 0.20 |
spinal cord, adult, donor10252.CNhs12227.10159-103A6 | 1086.30 | 65.35 | 0.89 | 0.59 | 0.30 |
spinal cord, fetal, donor1.CNhs11764.10056-101H2 | 492.39 | 36.77 | 1.69 | 1.27 | 0.85 |
spindle cell sarcoma cell line:Hs 132.T.CNhs11857.10737-110B8 | 1149.56 | 69.33 | 0.85 | 0.17 | 0.34 |
spleen, adult, pool1.CNhs10631.10025-101D7 | 400.94 | 118.04 | 0.38 | 0.85 | 1.79 |
spleen, fetal, pool1.CNhs10651.10044-101F8 | 471.19 | 69.87 | 0.71 | 0.77 | 1.55 |
splenic lymphoma with villous lymphocytes cell line:SLVL.CNhs10741.10424-106D1 | 602.94 | 94.84 | 1.10 | 0.50 | 0.30 |
squamous cell carcinoma cell line:EC-GI-10.CNhs11252.10463-106H4 | 654.04 | 69.64 | 0.54 | 0.54 | 0.89 |
squamous cell carcinoma cell line:T3M-5.CNhs11739.10616-108G4 | 668.03 | 79.75 | 0.71 | 0.00 | 0.35 |
squamous cell lung carcinoma cell line:EBC-1.CNhs11273.10486-107A9 | 291.92 | 29.29 | 0.64 | 0.40 | 0.40 |
stomach, fetal, donor1.CNhs11771.10062-101H8 | 1623.54 | 69.38 | 0.00 | 0.00 | 0.00 |
submaxillary gland, adult.CNhs12852.10202-103F4 | 367.44 | 49.08 | 1.83 | 2.29 | 0.00 |
substantia nigra, adult, donor10252.CNhs12318.10158-103A5 | 749.95 | 64.07 | 1.86 | 0.72 | 0.72 |
synovial sarcoma cell line:HS-SY-II.CNhs11244.10441-106E9 | 446.49 | 52.70 | 0.32 | 0.63 | 1.10 |
temporal lobe, adult, pool1.CNhs10637.10031-101E4 | 288.15 | 81.32 | 0.68 | 0.82 | 0.48 |
temporal lobe, fetal, donor1, tech_rep1.CNhs11772.10063-101H9 | 1014.95 | 18.76 | 1.31 | 3.93 | 0.00 |
duodenum, fetal, donor1, tech_rep2.CNhs12997.10071-101I8 | 596.21 | 57.66 | 3.70 | 2.65 | 0.53 |
tenocyte, donor1.CNhs12639.11763-123H8 | 704.19 | 63.24 | 5.58 | 1.49 | 0.00 |
tenocyte, donor2.CNhs12640.11765-123I1 | 772.30 | 53.15 | 4.16 | 2.31 | 0.92 |
tenocyte, donor3.CNhs12641.11768-123I4 | 633.37 | 68.35 | 9.95 | 2.60 | 1.30 |
teratocarcinoma cell line:PA-1.CNhs11890.10807-111A6 | 1300.78 | 31.79 | 1.64 | 1.01 | 0.13 |
teratocarcinoma cell line:NCC-IT-A3.CNhs11878.10790-110H7 | 924.71 | 51.25 | 1.75 | 0.55 | 0.55 |
teratocarcinoma cell line:NCR-G1.CNhs11884.10798-110I6 | 1610.46 | 34.97 | 3.42 | 3.17 | 0.00 |
testicular germ cell embryonal carcinoma cell line:ITO-II.CNhs11876.10786-110H3 | 1651.91 | 60.07 | 1.63 | 1.43 | 3.77 |
testicular germ cell embryonal carcinoma cell line:NEC14.CNhs12351.10591-108D6 | 2236.34 | 93.26 | 2.94 | 0.53 | 2.40 |
testicular germ cell embryonal carcinoma cell line:NEC15.CNhs12362.10593-108D8 | 3840.20 | 83.81 | 5.15 | 3.31 | 3.77 |
testicular germ cell embryonal carcinoma cell line:NEC8.CNhs11726.10590-108D5 | 1155.51 | 39.61 | 10.03 | 4.26 | 2.01 |
testis, adult, pool1.CNhs10632.10026-101D8 | 592.51 | 46.15 | 2.20 | 9.32 | 0.38 |
testis, adult, pool2.CNhs12998.10096-102C6 | 830.42 | 35.64 | 2.41 | 2.41 | 0.27 |
thalamus - adult, donor10196.CNhs13794.10168-103B6 | 488.38 | 75.45 | 0.00 | 2.49 | 0.00 |
thalamus, adult, donor10252.CNhs12314.10154-103A1 | 841.63 | 68.06 | 0.83 | 0.83 | 0.93 |
throat, adult.CNhs12858.10209-103G2 | 392.56 | 54.16 | 1.49 | 1.92 | 1.71 |
throat, fetal, donor1.CNhs11770.10061-101H7 | 835.61 | 42.85 | 2.14 | 0.71 | 0.48 |
thymus, adult, pool1.CNhs10633.10027-101D9 | 686.58 | 71.50 | 2.39 | 2.45 | 1.03 |
thymus, fetal, pool1.CNhs10650.10043-101F7 | 576.98 | 61.33 | 1.68 | 0.74 | 1.43 |
thyroid carcinoma cell line:TCO-1.CNhs11872.10783-110G9 | 453.91 | 35.21 | 0.67 | 0.45 | 0.00 |
thyroid, adult, pool1.CNhs10634.10028-101E1 | 625.78 | 69.88 | 1.59 | 1.78 | 0.57 |
thyroid, fetal, donor1.CNhs11769.10060-101H6 | 985.73 | 42.65 | 0.61 | 1.41 | 0.00 |
tongue, adult.CNhs12853.10203-103F5 | 423.89 | 49.86 | 3.92 | 2.61 | 0.22 |
tongue, fetal, donor1.CNhs11768.10059-101H5 | 1012.67 | 34.91 | 3.76 | 1.37 | 0.00 |
tonsil, adult, pool1.CNhs10654.10047-101G2 | 373.67 | 91.26 | 0.27 | 0.34 | 0.34 |
trachea, adult, pool1.CNhs10635.10029-101E2 | 389.02 | 77.75 | 1.08 | 0.57 | 1.15 |
trachea, fetal, donor1.CNhs11766.10058-101H4 | 690.94 | 33.93 | 2.00 | 1.00 | 0.33 |
transitional-cell carcinoma cell line:5637.CNhs10735.10418-106C4 | 369.65 | 28.08 | 0.24 | 0.49 | 0.33 |
transitional-cell carcinoma cell line:JMSU1.CNhs11261.10492-107B6 | 595.97 | 50.48 | 2.88 | 0.96 | 0.53 |
tridermal teratoma cell line:HGRT.CNhs11828.10694-109G1 | 2950.14 | 106.19 | 0.00 | 0.00 | 1.93 |
tubular adenocarcinoma cell line:SUIT-2.CNhs11883.10797-110I5 | 1742.88 | 76.35 | 1.80 | 1.53 | 0.72 |
umbilical cord, fetal, donor1.CNhs11765.10057-101H3 | 804.82 | 68.05 | 2.35 | 0.00 | 0.00 |
uterus, adult, pool1.CNhs11676.10100-102D1 | 827.57 | 45.96 | 1.34 | 0.61 | 1.10 |
uterus, fetal, donor1.CNhs11763.10055-101H1 | 769.44 | 29.70 | 2.44 | 3.26 | 0.81 |
vagina, adult.CNhs12854.10204-103F6 | 1026.60 | 57.92 | 0.00 | 3.99 | 1.33 |
vein, adult.CNhs12844.10191-103E2 | 511.44 | 95.40 | 1.81 | 1.41 | 0.40 |
xeroderma pigentosum b cell line:XPL 17.CNhs11813.10563-108A5 | 1104.04 | 94.89 | 2.89 | 1.28 | 0.32 |